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ABSTRACT 
Psychological and Sociocultural Influences of Current and Historical Intimate Partner Violence 
in Pregnancy 
by 
Cindy DuPre’ Phillips 
The Centers for Disease Control and Prevention (CDC) estimates that 1.5 million women are 
victims of intimate partner violence (IPV) each year, and 324,000 of these women are pregnant 
(2013).  Research on the predictability of certain factors and their relationship to current and 
historical IPV is limited.  In order to better understand IPV as it related to a sample of 1,016 
Appalachian pregnant women selected for the Tennessee Interventions for Pregnant Smokers 
(TIPS), it was important to evaluate various influences that may predict the prevalence of IPV in 
this population when compared to the State of Tennessee and the U.S. (Aim 1).  An evaluation of 
psychological, sociocultural, and socioeconomic variables as they relate to both current and 
historical IPV in pregnant women presenting for prenatal care was conducted (Aim 2), and the 
results from this evaluation were used to model significant IPV influences to determine 
pregnancy predictors in the study sample when historical and current IPV is present (Aim 3). 
Percent prevalence of self-reported IPV was higher in the TIPS sample for Carter, Greene, 
Hawkins, Johnson, Sullivan, Washington, and Unicoi counties, when compared to criminal 
reports for State of Tennessee IPV victimization rates, and the rate per 1,000 IPV victimization 
rate was also higher in the TIPS sample when compared to the criminal report for the U.S.  Self-
esteem, social, support, stress, substance abuse, and alcohol were positive as independent effects 
for predicting IPV via ordinal regression; however, when evaluated via multinomial logical 
regression with controls for age, race, income, education, marital status, whether or not a 
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pregnancy was planned, and parity, this effect was no longer noted.  Unplanned pregnancies and 
lower education were significant control variables in these evaluations.  The lack of support for 
predictive ability of those selected psychological and sociocultural variables for IPV only 
underscores the importance of taking into consideration the uniqueness of various populations 
and across various regions such as Appalachia.  The influences of unplanned pregnancy and 
lower education may be significant predictors if IPV in pregnant women in Appalachia and 
warrant further research.  
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CHAPTER 1 
INTRODUCTION 
 The Centers for Disease Control and Prevention (CDC) estimates that 1.5 million women 
are victims of intimate partner violence (IPV) each year, and 324,000 of these women are 
pregnant (2013).  While anyone can be the victim of violence, women are more likely to 
experience violence at the hand of a current or past male intimate partner (Heise, Ellsberg, & 
Gottemoeller, 1999).  IPV may take the form of sexual, psychological/emotional, physical, or 
financial victimization, and many women experience a combination of one or more of these 
types of violence and abuse concurrently (World Health Organization [WHO], 2012).  Further, 
women experiencing both physical and psychological abuse are more likely to have increased 
depression, substance abuse, and mental illness (Coker et al., 2002a).   
 Mental illness in pregnant women experiencing IPV has been evaluated in diverse 
forums.  Various life stressors and diminished or absent social support can contribute to the 
development of increased stress, depression, and low self-esteem in pregnancy (Flanagan, 
Gordon, Moore, & Stuart, 2015; Groves, Kagee, Mamen, Moodley, & Rouse, 2012).  Women 
experiencing IPV in pregnancy are known to have higher levels of stress and depression 
(Flanagan et al., 2015), but the prevalence and variety of mental illness and mental health 
disorders in pregnancy is not well documented (Ludermir, Valonguiero, & Barreta de Araujo, 
2014; Rose et al., 2010). Concomitant historical or current IPV has had limited evaluation in the 
context of modeling direct influences of psychological and emotional abuse in women. 
Controlling for sociocultural and socioeconomic covariates could assist in understanding the 
potential influence of these factors in the presence of IPV in pregnancy. 
 
 
16 
 
 Socioeconomic associations have frequently been evaluated or controlled for in studies 
involving pregnant women experiencing IPV. Low socioeconomic status (SES) has been 
associated with increased IPV (Tzilos, Grekin, Beatty, Chase, & Ondersma, 2010), but small 
sample sizes have limited the ability to generalize this association to larger populations.  Other 
sociocultural factors such as substance or alcohol abuse may instead demonstrate a relationship 
with IPV that could better explain predictors of IPV both before and during pregnancy. 
 Substance abuse (SA) and alcohol (ETOH) abuse during pregnancy have been studied 
individually and in combination with other socioeconomic indices and IPV (Cunradi, Caetano, & 
Schafer, 2002).  When examined as a precursor to IPV, some evidence suggests that SA can be a 
cause of IPV, while others believe that SA is a separate outcome of IPV that exists in an intimate 
relationship (Bennett & Bland, 2011). The effect of SA on psychological stress, degrees of social 
support, and levels of self-esteem in pregnancy in the presence of IPV has been studied most 
often in the context of various sequelae of SA itself (Bennett & Bland, 2011; Campbell, 2002).  
While existing studies have established one or more factors that explain IPV in a set population 
sample, it is important to understand the role of psychological, socioeconomic, and sociocultural 
influences in order to better assess and plan interventions for IPV prevention in pregnancy.  
Research Aims 
 IPV has been studied extensively in various cultures and in pregnancy in an attempt to 
develop better methods for screening this vulnerable population, and to identify cycles of abuse 
earlier to disrupt the continuity of abuse in subsequent generations.  In order to better understand 
IPV as it relates to a sample of Appalachian pregnant women selected for the Tennessee 
Interventions for Pregnant Smokers (TIPS), it is important to evaluate various influences that 
may predict the prevalence of IPV in this population.  An evaluation of psychological, 
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sociocultural, and socioeconomic variables as they relate to both current and historical IPV can 
assist providers to better assess, plan, and intervene when IPV is identified in pregnant women 
presenting for prenatal care.    
 The principal aim of the current study is to evaluate various psychological, sociocultural, 
and socioeconomic variables as potential predictors of both current and historical IPV.  There are 
three aims for this study that will be examined.  Aim 1 will evaluate the prevalence of historical 
and current IPV in the study sample, which will then be contrasted against historical IPV 
victimization rates in the State of Tennessee and the United States (US).  Aim 2 will divide the 
study sample into IPV subgroups, which will determine the strength of associations against 
various sociocultural covariates in predicting IPV.  Finally, Aim 3 will then model significant 
IPV influences from Aim 2 to determine pregnancy predictors in the study sample when 
historical and current IPV is present. 
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CHAPTER 2 
LITERATURE REVIEW 
Theories of IPV 
Existing Theoretical Frameworks 
 Biological, psychological, feminist, social learning, and ecological theories have all been 
proposed as explanatory perspectives for IPV (Ali & Naylor, 2013).  Biological theories of IPV 
attempt to determine physiological sources of IPV behavior such as prior head injuries, 
neurological disorders or dysfunction, or variations in the human genome (Pinto et al., 2010).  
Psychological theories are quite varied with respect to their explanation of factors associated 
with IPV and include such considerations as mental illness or mental disorders, substance and 
alcohol abuse, and disorders of communication and assertiveness (Bell & Naugle, 2008; Coker et 
al., 2002a; Golding, 1999). Feminist theories tend to frame IPV in terms of the ongoing struggle 
of women and female inequality in a male-dominated society where traditional male-female roles 
are supported (Bell & Naugle, 2008; McPhail, Busch, Kulkarni, & Rice, 2007; Palitto & 
O’Campo, 2005). Social learning theorists have integrated Intergenerational Transmission 
Theory and Male Peer Support Theory (Sellers, Cochran, & Branch, 2005), as well as Theories 
of Family Conflict and the Consequences of Aggression (Bell & Naugle, 2008).   Finally, 
ecological theorists attempt to clarify how the interplay of the individual, family, community, 
and society interact to explain the dynamics of both the occurrence of IPV and those factors that 
shape the abuser (Little & Kantor, 2010; Oetzel & Duran, 2004). 
Theory of Current Study 
 The attempt of the current study is to evaluate various factors that may predict IPV in 
pregnant women.  Ecological, psychological, and social theories could conceptualize these 
suppositions in the current study population.  First, ecological theory is visually conceptualized 
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as layers of circles with the individual at its center, and family, community, and society surround 
the individual as systems of influence (Bronfenbrenner, 1994).  Pregnant women represent the 
individual of concern, with a set of psychological and biological factors that shape how she 
interacts with a potential abuser (Kelly, 2011).  Substance and alcohol abuse can affect the 
individual in this layer of influence (Kelly, 2011).  The next layer involves those relationship 
factors that could precipitate IPV including various controlling or power roles of males in the 
home while growing up, during a current intimate relationship, or witnessing marital or 
relationship discord in parental figures during formative years (Kelly, 2011).  At the third level 
of influence are the external factors that exist to either discourage or perpetuate violence in a 
given community or society (Kelly, 2011).  This theory could then be appropriate for the current 
study when evaluating the roles of substance and alcohol abuse, psychological factors internal 
and external to the individual pregnant women, and stress factors which may create vulnerability 
in some women (Kelly, 2011). Second, psychological theory has been used to examine the both 
the abuser and the abused.  Evidence suggests that individuals who do not grow up in a 
supportive and nurturing environment, have less self-confidence and self-esteem to manage 
stress and anxiety, and may, therefore, be predisposed to either be abused or be abusive as adults 
(Blizard & Bluhn, 1994; Cogan & Porcerelli, 1996; Cogan, Porcerelli, & Dromgoole, 2001; 
Dutton, Starzomski, & Ryan, 1996).  Psychological theory could then be in support of the 
contention that variations in support and self-esteem could influence IPV both before and during 
pregnancy.  Third, social theorists suggest that violence is a stress response that may occur in an 
environment where other stressors such as negative peer and family influences and financial 
hardships exist concurrently (Straus, 1980).  Stress could then be an important predictor of IPV 
in current or historical IPV for the study sample. Precursors to IPV are thus conceptually varied, 
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but defining various types of abusive behavior and their impact on women and pregnancy can 
assist in further clarifying IPV for the current study.  
Abusive Behaviors in Pregnancy 
 While types and kinds of violence and their definitions can vary, it is commonly accepted 
that IPV typically includes coercive behaviors involving power and control between one or more 
individuals that occurs over various periods of time (Danis & Bhandari, 2010).  Women 
experiencing abuse report acts or injury that are most often caused by an intimate partner or 
spouse (Office on Women’s Health, 2012).  Physical, sexual, and psychological/emotional IPV 
can then be defined in terms of behaviors that cause harm to women before or during pregnancy 
for the present study. 
Defining Physical Abuse in Pregnancy 
 Physical IPV is defined as by the U.S. Department of Justice as any behavior that causes 
injury or wounds to the body by one person to another (2015).  It is estimated that one in three 
women over the age of 12 have experienced physical violence which can also include sexual acts 
causing physical harm, and greater than 300,000 women experiencing IPV each year are 
pregnant (CDC, 2013). Approximately 2.9 per 100,000 women are also victims of pregnancy-
associated homicide as a result of escalating physical violence in pregnancy (Palladino, Singh, 
Campbell, Flynn, & Gold, 2011).  Pregnancy may also create an opportunity for the initiation of 
violence against women or for existing IPV to escalate (Jasinski, 2004; McFarlane & Gondolf, 
1998).  Pregnancy in and of itself is not a protective factor against physical IPV (WHO, 2011), 
and severe forms of physical IPV can result in death or debilitating injury to mothers and unborn 
infants (WHO, 2012).    
 Extreme Forms of Physical IPV. Adverse health outcomes as a result of IPV in 
pregnancy include complications such as preterm delivery, low-birth weight, and fetal demise 
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(CDC, 2015). Case studies have reported on the deleterious impacts of extreme IPV, including 
late-term fetal demise due to spleen and liver lacerations noted following blows to the mother’s 
abdomen (Jain, Bagde, & Samal, 2014), and development of fetal hydrops and anemia in a 
previously normal second-trimester pregnancy (Pekin, Yilmaz, & Kerimoglu, 2014).  Larger 
domestic and international population-based IPV studies involving pregnant women of various 
ages have revealed increased risk of spontaneous abortion, vaginal bleeding, placental abruption 
with and without fetal demise, and stillbirth (Finnbogad/ ttir, Dykes, & Wann-Hansson, 2014; 
Han & Stewart, 2014; Haywood, 2014). 
 The most extreme form of IPV in pregnancy may result in maternal homicide.  National 
and state crime statistics, as well as specific databases created to monitor sources of maternal 
morbidity and mortality, have allowed greater insight into this occurrence.  Data from the 2003-
2007 National Violent Death Reporting System revealed that pregnant women experiencing IPV 
had 2.9/100,000 deaths (Palladino et al., 2011).  A study of death certificates in North Carolina 
revealed that 59 out of 167 pregnant women examined (35.5%) suffered homicide after injuries 
caused by IPV (Harper & Parsons, 1997), and 63% of 115 New York maternal homicides over a 
four-year period were confirmed via autopsy reports to be the result of IPV during pregnancy 
(Dannenberg et al., 1995).  Variations in recording causes of death from state to state and region 
to region may complicate an accurate analysis of this statistic as a principle source of data, but 
efforts by the CDC (n.d.) and local governments to educate state reporting agencies about 
uniform reporting practices have assisted in increasing the accuracy of this reporting.   
Defining Sexual Abuse in Pregnancy 
 The CDC defines sexual violence as any sexual act that is perpetrated by an individual 
without the complete consent of the other individual (2015).  Sexual violence can include actual 
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or complete penetration, date rape with or without the use of incapacitating drugs or alcohol, 
sexual acts under coercion, and forced, unwanted sexual contact towards other persons (CDC, 
2015).  Sexual violence can also increase during the second trimester of pregnancy (Karaoglu et 
al., 2005), and can be a contributor to miscarriage in early pregnancy (Ismayilova & El-Bassel, 
2014; Johri et al., 2011). 
Defining Psychological Abuse in Pregnancy 
 Psychological abuse can be defined as acts which can cause mental trauma, acute or 
chronic anxiety, depression, or post-traumatic stress disorder (PTSD) in the victim (Maiuro & 
O’Leary, 2000), with PTSD and depression being the most prevalent consequences of 
psychological abuse (Cascardi, O’Leary, & Schlee, 1999).  Perpetrators of psychological abuse 
often intend to inflict emotional harm, and this harm is often the cause of low self-esteem, high 
personal and familial stress, and high levels of personal anxiety (National Institutes of Health 
[NIH], 2014).  Studies in both the U.S. and abroad have evaluated the significance of various 
aspects of psychological abuse in pregnancy.   
 Domestic Evaluations of Psychological Abuse in Pregnancy. A meta-analysis of 67 
U.S. studies attempted to determine the association between anxiety, stress and PTSD in the 
antenatal and postpartum periods.  The meta-analysis concluded that there was an increased 
likelihood of developing post-partum PTSD, depression, and anxiety when IPV was present 
(OR=3.1) in the perinatal period (Howard, Oram, Galley, Trevillion, & Feder, 2013).  A limiting 
characteristic of this analysis was the inclusion of only those studies that had assessed mental 
health during pregnancy.   
 International Evaluations of Psychological Abuse in Pregnancy. A study of 1,500 
African women demonstrated that women experiencing IPV were more likely to develop 
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emotional distress with each subsequent episode of psychological abuse experienced during 
pregnancy (OR=1.41); however, this sample was limited to Human Immunodeficiency Virus 
(HIV) positive mothers (Groves et al., 2012). A study of 283 Hispanic pregnant women was 
found to be 51.2% more likely to develop psychoemotional disturbances when IPV was present 
(Salazar-Pousada et al., 2012), but the study sample was limited to women with existing high-
risk pregnancy conditions. Another study of pregnant Hispanic women also found 45.2% 
increased likelihood of experiencing depression in the prenatal period when IPV was present 
when compared with women not experiencing IPV, and a major strength of this study was its 
longitudinal design (Rodriguez et al., 2010).   
 All forms of IPV are thus associated with risk of harm or injury for pregnant women.  
IPV in pregnancy may include physical, sexual, or psychological, abuse, and it is possible for 
one or more of these types of abuse to occur simultaneously (CDC, 2012).  It is a first step to 
define behavior classified as abuse in pregnancy, but other factors may aid in identifying 
relationships between IPV and maternal behaviors that may place them at increased risk for IPV.  
Such behaviors can include maternal substance and alcohol abuse. 
Maternal Substance Abuse in Pregnancy 
 Women experiencing substance abuse during pregnancy are more likely to be 
undertreated for mental illness and more likely to be victims of IPV (Goodman & Wolff, 2013).  
According to the 2013 National Survey on Drug Use and Health, 7.3% of women surveyed had 
used one or more illicit drugs in the month preceding the survey, and 5.4% of women aged 15-44 
used illicit substances while pregnant. Pregnant women experiencing IPV are more likely to 
abuse illicit substances (OR=4.4) (McCauley et al., 1995), and those women experiencing 
physical IPV were most likely to engage in substance abuse (Coker et al., 2002a; Martin, 
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Beaumont & Kupper, 2003). A variety of illicit substances have been found to be used during 
pregnancy including opioids, cocaine, methamphetamines, marijuana, sedatives, alcohol, and 
tobacco; however, relationships between specific illicit substances and associations with IPV 
have had limited evaluation in the literature. 
Opioids Use in Pregnancy 
  Absent from studies involving opioid addiction in women is establishing whether IPV 
was present before or during pregnancy, and whether or not IPV could have been a contributing 
factor when maternal opiate addiction was present.  Instead, it is more common to note an 
increased risk of substance abuse overall when IPV is present when controlling for demographic 
and mental illness covariates (Chermack et al., 2014). Valuable information has been noted, 
however, about opioid addiction and pregnancy irrespective of IPV being present. 
 Opioid Statistics in Pregnancy. The use of opiates such as heroin, morphine, and 
narcotics among women has been extensively studied for greater than 15 years.  Opiates are 
highly addictive, and women transition from opiate use to abuse more rapidly than do men 
(SAMSHA, 2013). Heroin remains the most commonly abused opiate in men and women 
(SAMSHA, 2013), and the National Institute of Drug Abuse (NIDA) estimates that every 25 
minutes a baby is born experiencing opioid withdrawal (2015). 
 Opioid Outcomes from Use in Pregnancy. An earlier meta-analysis of maternal 
complications associated with opioid use noted a positive association between maternal opioid 
use and an increased risk of antepartum hemorrhage (Pooled OR=2.33) (Hulse, Milne, English, 
& Holman, 1998), but no notation of IPV as an associated covariate for opioid misuse was 
indicated.  An evaluation of opioid use during pregnancy from the National Inpatient Sample 
(NIS) from 1999-2009 was, however, associated with an increased risk of mental illness to 
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include anxiety and depression, increased odds of pregnancy complications such as pre-term 
labor and premature rupture of membranes (PROM) (OR 1.36 and 1.1 respectively), and higher 
costs associated with hospital admission and care (Whiteman et al., 2014). Other research has 
focused instead on the use of methadone or buprenorphine for the prevention of maternal opiate 
withdrawal and fetal demise during pregnancy (Jones, et al., 2012; Jones et al., 2013; Pritham, 
Paul, & Hayes, 2012; Unger, Jung, Winklbauer, & Fischer, 2010), but the presence of IPV as a 
factor of potential influence has not been evaluated as part of these studies. Because it is 
necessary to treat women with opiate addiction during pregnancy with medications such as 
methadone, and buprenorphine with naloxone (Suboxone), exploring the role of medication used 
for opiate addiction management and its possible relationship to IPV is also important. 
 Methadone as a Treatment for Opioid Addiction in Pregnancy and IPV. Methadone 
has been frequently used to assist with supervised narcotic withdrawal from opiate addiction for 
over 40 years (MedlinePlus, 2014).  Methadone is a Pregnancy Category C medication, meaning 
that risk to a developing fetus cannot be ruled out, and it is a Controlled Substance Abuse (CSA) 
Schedule 2 medication classified as having a high potential for abuse (U.S. Department of 
Justice, n.d.).  Obstetricians recommend its use in pregnancy only if a women is enrolled in a 
licensed addiction specialist facility (ACOG, 2012b). 
 The relationship between methadone use in pregnancy and IPV has had no evaluation in 
the literature.  What has been investigated is the relationship of methadone treatment among 
women experiencing IPV and their mental health as well as their other drug use. After 
controlling for age, gender, education, and ethnicity, one study found that women using 
methadone and experiencing IPV had higher depression scores on the Center for 
Epidemiological Studies Depression Scale (CES-D) (p<.05), and were six times more likely to 
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also use cocaine (OR=6.65); pregnancy was not evaluated as part of this study (de Dios, 
Anderson, Caviness, & Stein, 2014). A longitudinal study examined women using methadone at 
baseline, six months, and twelve months, found that these women were four times more likely to 
report IPV (OR=4.4), and were also more likely to concurrently use cocaine, marijuana, and 
heroin; pregnancy was also not evaluated as part of this study (El-Bassel, Gilbert, Wu, Go, & 
Hill, 2005). 
 Buprenorphine as a Treatment for Opioid Addiction in Pregnancy and IPV. 
Buprenorphine is a newer medication that is also used to treat opiate withdrawal and 
dependence, and is also classified as a Pregnancy C Category medication. (MedlinePlus, 2015).  
It is a CSA Schedule III narcotic, which indicates that while it is likely to lead to low or 
moderate levels of physical abuse, it has a high likelihood to cause psychological addiction (U.S. 
Department of Justice, n.d.). Buprenorphine is used more often with pregnant women due to 
evidence indicating that hospital stays for infants born to them are shorter in length than women 
taking methadone, infants have less severe Neonatal Abstinence Syndrome (NAS), and infants 
require less morphine to treat withdrawal than those born to mothers using methadone (Jones et 
al., 2012). Studies involving pregnancy, IPV, and the use of buprenorphine have not been found 
in the literature. It is more common to encounter studies in the literature that evaluate the 
efficacy of maternal buprenorphine use to treat opiate addiction, and its role in reducing the 
incidence and severity of NAS and other adverse fetal outcomes (Jones et al., 2012). 
Cocaine Use in Pregnancy 
 Similarly, cocaine use in pregnancy has been well studied since the late 1980s mainly in 
terms of neonatal and pregnancy outcomes.  Cocaine abuse in pregnancy has been associated 
with pregnancy complications, mental health complications, and fetal complications (NIDA, 
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2010). Assessments of concurrent IPV with maternal cocaine addiction are generally absent from 
published findings. One 10-year study found an increased relationship between physical and 
sexual abuse and cocaine addiction later in life among pregnant women (p<.001) (Jantzen, Ball, 
Leventhal, & Schottenfeld, 2012).  Another study of pregnant women presenting to an 
emergency department (ED) for treatment found that those that had used cocaine in the 
preceding six months were more likely to experience injurious IPV (OR=2.35, p<.05) than 
women using other illicit substances (Gilbert et al., 2012). Studies and statistical data in 
pregnancy when IPV is not a covariate are also valuable in understanding potential fetal or 
maternal complications. 
 Cocaine Statistics in Pregnancy. When studying the relationship between maternal 
cocaine use and pregnancy and mental health complications, women who used cocaine in 
pregnancy were noted to be more likely to begin prenatal care in the second trimester or later 
(53.1%) or have no prenatal care (25.8%) (Flavin, 2002). Suicide, aggression, and psychosocial 
impairment were found to be the most prevalent mental illness in pregnant women presenting for 
hospitalization due to cocaine abuse (Eggleston et al., 2009). Decreased perception of personal 
mental health, poorer overall health, increased concurrent alcohol and tobacco use, and increased 
family strain were also more prevalent in a 10-year study of pregnant cocaine abusers (Minnes et 
al., 2012).  
 Cocaine Outcomes from Use in Pregnancy. Fetal complications related to maternal 
cocaine ingestion have been well documented in the literature.  In general, it is well supported 
that babies born to women abusing cocaine had lower birth weights, were shorter in length, and 
had smaller head circumferences (Fox, 1994; NIDA, 2010; Slutsker, 1992). It has been suggested 
that premature rupture of membranes (PROM), spontaneous abortion, pregnancy-induced 
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hypertension (PIH), and fetal death have been associated with maternal cocaine use, but studies 
have not consistently established these links to be true in all cases of maternal cocaine abuse with 
subsequent fetal complications (Fox, 1994; NIDA, 2010; Slutsker, 1992). 
 Another group of studies has suggested that maternal cocaine ingestion is also associated 
with developmental or behavioral problems in children after birth.  Several of these studies were 
longitudinal in nature and have created a growing knowledge base for understanding 
developmental, behavioral, and learning issues in children of cocaine-addicted mothers (Bada et 
al., 2012; Gringas, Weese-Mayer, Hume, & O’Donnell, 1992; Minnes et al., 2012). Larger U.S. 
studies, however, have not substantiated this association. Using the Bayley Scale of Infant 
Development (BSID), researchers in Pittsburgh and Boston found no association between infant 
mental performance and growth and maternal cocaine use when compared to nonexposed infants 
(Frank et al., 2002; Richardson, Goldschmidt, & Willford, 2007).  Detroit researchers evaluated 
school-age boys and girls for externalizing behaviors associated with maternal cocaine use 
during pregnancy, and after controlling for confounders and concurrent fetal alcohol exposure, 
no association between maternal cocaine use and delinquent or aggressive behaviors was found 
(Bailey, et al., 2005).  
Sedative Use in Pregnancy 
 Little evidence exists in the literature to support a link between maternal sedative use and 
IPV.  Sedative use during pregnancy is more likely to be evaluated with other illicit substance 
use, or it is examined in relationship to the role of maternal sedative use in the development of 
NAS (Wilson & Thorp, 2008).  Psychological aggression and level of physical aggression in men 
entering treatment for alcoholism in one study was noted to have a relationship to their female 
partner’s sedative use (p<.05) (Mattson et al., 2012). 
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 Sedative Statistics in Pregnancy. According to the 2010 National Survey on Drug Use 
and Health, approximately 4.4% of women aged 15-44 used illicit substances, and approximately 
2.4% of pregnant women surveyed admitted to using sedatives not prescribed to them or taking 
them to feel their effects (SAMSHA, 2011). Abuse of sedatives typically occurs with other illicit 
substances, long-term use of sedatives can cause addiction, and abrupt withdrawal of sedatives 
can be life-threatening both to mothers and their unborn infants (ACOG, 2012). 
 Sedative Outcomes from Use in Pregnancy. Sedative medication includes many 
individual medications such as benzodiazepines.  Existing studies in the literature are diverse in 
that some study the effects of an individual medication on pregnancy, others have examined 
sedative use with other types of medication, but there is scant evidence of studies that examine 
sedatives as a class exclusively.  An earlier matched case-control study evaluating congenital 
outcomes after short-term exposure to diazepam (or Valium, a benzodiazepine sedative) in the 
second and third months of pregnancy found a higher incidence of limb malformations, 
cardiovascular malformation, and anal atresia in the case population (OR= 3.9, 5.2, and 1.3 
respectively) (Czeizel et al., 2003).  Another study of the relationship of sedative and selective 
serotonin reuptake inhibitors (SSRIs) in pregnancy to adverse fetal outcomes found that women 
taking both medications had a higher risk for congenital malformations and cardiac defects 
(OR=1.17) (Reis & Källén, 2013). A meta-analysis of 16 studies on the use of benzodiazepines 
in pregnancy, however, found that there was no increased risk of congenital malformations 
associated with these medications, but there was an increased risk of low birth weight, preterm 
birth, and SGA infants noted (Okun, Ebert, & Saini, 2015).   
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 Methamphetamine Use in Pregnancy 
 Little evidence exists in the literature to support a link between maternal 
methamphetamine use and IPV.  Smaller sample sizes, and the fact that mothers often use other 
illicit substances concurrently, have produced limited evidence evaluating a potential association 
between methamphetamine use, associated pregnancy complications, and IPV as a covariate 
(NIDA, 2013). One study of 273 pregnant women conducted in Los Angeles that included IPV 
as a covariate determined that women actively using methamphetamine before and during 
pregnancy were more likely to use other drugs of abuse, be unemployed, and be victims of IPV 
when compared to a control group (Good, Solt, Acuna, Rotmensch, & Kim, 2010). While the 
pool of literature relating IPV to maternal methamphetamine use is small, other studies have 
added valuable information that can assist in understanding maternal or fetal complications 
related to maternal methamphetamine use.  
 Methamphetamine Statistics in Pregnancy. In the U.S., methamphetamine-associated 
hospital admissions in pregnant women rose from eight to 24 percent between 1994-2006 
(Terplan, Smith, Kosloski, & Pollack, 2009).  As of 2013, SAMSHA estimated that greater than 
400,000 women aged 18-45 in their reproductive years used methamphetamines in the preceding 
month.  Methamphetamine abuse in northeastern Tennessee (TN), southwestern Virginia (VA), 
southeastern Kentucky (KY), southern West Virginia (WV), and western North Carolina (NC) 
has also become a growing problem that has become a focus for national scrutiny (Jonsonn, 
2003; Kranitz & Murrmann, 2013; Rayman, 2006; Schultz, 2010; The-CNN-Wire, 2014). 
 Methamphetamine Outcomes from Use in Pregnancy. Current literature has 
documented some evidence of maternal and fetal complications related to maternal 
methamphetamine use, and the first generations of children born to meth-addicted mothers are 
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beginning to be examined in studies of birth outcomes.  Existing studies have established that 
infants born after intrauterine methamphetamine exposure are more likely to be small for 
gestational age (SGA) overall, and have small head circumference and lengths (Smith et al., 
2003; Smith et al., 2008).  A study of 50 infants born to mothers using methamphetamine during 
pregnancy were more likely to have a lower APGAR score at five minutes (p=.048), lower levels 
or arousal (p=.014) and increased lethargy (p=.008) when compared to the control group (Paz et 
al., 2009). Neurodevelopmental outcomes in toddlers aged one to three demonstrated delayed 
fine motor and cognitive skills after prenatal methamphetamine exposure, and meth addiction 
has demonstrated positive associations with maternal depression and increased stress during 
pregnancy (Paz et al., 2009; Wouldes et al., 2014). While these studies have included maternal 
sociocultural characteristics such as social support, stress, and mental health as being affected by 
maternal methamphetamine abuse, IPV has not been concurrently evaluated. 
Marijuana Use in Pregnancy 
 The literature is also limited when evaluating marijuana (cannabis) use in pregnancy and 
its association with IPV prevalence.  A study of three urban OB-GYN clinics reported a 
significant association (P<.01) between mothers who used marijuana and the occurrence of IPV 
(Alhusen, Lucea, Bullock, & Sharpe, 2013).  Any type of physical IPV was also noted to 
increase marijuana use before conception and in the intrapartum period when compared with 
non-substance abusing, non-IPV mothers (P<0.05) (Bailey & Daugherty, 2007).  A study of 166 
mothers who abused marijuana in pregnancy were also noted to be five times more likely to 
experience IPV (OR=5.16) and have a SGA infant (OR=5.00) (Alhusen, Lucea, Bullock, & 
Sharps, 2013). Studies evaluating marijuana use in pregnancy, with or without the presence of 
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IPV, have also contributed to the understanding of potential maternal or fetal complications 
associated with cannabis use. 
 Marijuana Statistics in Pregnancy. The Substance Abuse and Mental Health Services 
Administration (SAMSHA) (2013) has estimated that approximately 5% of women will use 
marijuana at some point in their pregnancy. Marijuana use will usually continue in pregnancy for 
approximately 48-60% of women because it is believed to be as safe as, and cheaper than, 
purchasing tobacco (Beatty, Svikis, & Ondersma, 2012; Passey, Sanson-Fisher, D’Este, & 
Stirling, 2014).  Marijuana is often used in pregnancy with other illicit substances and tobacco, 
and this can make is difficult to conclusively determine the unique effects of marijuana on 
pregnancy (ACOG, 2015a).  
 Marijuana Outcomes from Use in Pregnancy. While there is diversity in the literature 
regarding the impact of marijuana use on fetal outcomes, it is widely accepted that deficits in 
higher ordered thinking, attention deficit, and impulsivity are noted in school-age children whose 
mothers regularly abused marijuana during pregnancy (Fried, O’Connell, & Watkinson, 1992; 
Fried & Smith, 2001; Leech, Richardson, Goldschmidt, & Day, 1999).  In addition, women using 
marijuana at least once weekly were more likely to have infants with low birth weights, smaller 
lengths and smaller head circumferences (Cornelius et al., 1995; Day et al., 1992; Fergusson et 
al., 2002). 
Alcohol Use in Pregnancy 
 IPV has been associated with alcohol abuse and misuse in pregnancy.  Pregnant women 
experiencing IPV were more likely to drink alcohol than women not experiencing IPV (Martin, 
Beaumont, & Kupper, 2003). Other research has also examined maternal influences such as IPV 
that could contribute to a mother’s decision to drink alcohol during pregnancy.  A study of 308 
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women with low socioeconomic status was unable to demonstrate differences in two groups of 
women that were either positive or negative for IPV before conception, and the decision to 
continue drinking alcohol once pregnancy was diagnosed (p=0.155) (Alvanzo & Svikis, 2008). 
Another study of low-income pregnant women found that those experiencing physical or sexual 
IPV were more than twice as likely to use alcohol (OR=2.53, p=.003) (Li et al., 2010). Since 
alcohol use in pregnancy has also been widely studied when IPV is not a covariate, such studies 
also provide important information to assist in understanding potential maternal or fetal 
complications. 
 Alcohol Statistics in Pregnancy. In 2012-2013, it was estimated that among pregnant 
women aged 15-44, 9.4 percent admitted to drinking alcohol, 2.3% engaged in binge drinking, 
and 0.4% admitting to heavy drinking (SAMSHA, 2013). The Department of Health and Human 
Services defines pregnancy “risky drinking” as more than seven drinks per week, or more than 
three drinks in one sitting (2007).  It is for this reason that women are advised to reduce or 
discontinue alcohol ingestion prior to conception to avoid risk to the developing fetal brain in a 
pregnancy that may not yet be confirmed (Chang, McNamara, Orev, & Wilkins-Haug, 2006).   
 Alcohol Outcomes from Use in Pregnancy. The teratogenic effects of alcohol ingestion 
and subsequent diagnosis of Fetal Alcohol Syndrome were first documented in 1973 (Jones & 
Smith, 1973).  Early effects of alcohol in pregnancy focused on developmental delays 
documented in children born to alcohol-abusing mothers.  Maier and West (2001) reported that 
binge drinking was harmful to a developing fetal brain, and that drinking alcohol early in 
pregnancy could be as detrimental as drinking during an entire pregnancy. 
 Substance abuse and alcohol abuse are often seen together in studies of pregnant women. 
An evaluation of pregnancies documented in the Nationwide Inpatient Sample (NIS) from 1999-
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2008 demonstrated an overall reduction in alcohol ingestion with a subsequent rise in cannabis, 
hallucinogens, sedatives, and other unspecified drugs among pregnant women (Pan & Yi, 2013).  
An earlier study of 60 Hispanic women found equivocal results for alcohol and substance abuse 
in pregnancy, and while the study sample was small, substance misuse was weighted against 
social support and stress as correlates for the study findings (Lindenberg et al., 1999).   
Tobacco Use in Pregnancy 
 A recent meta-analysis examined the strength of the relationship between tobacco and 
IPV, and found that of the 31 studies included in the analysis, pregnant victims of IPV were 
more likely to abuse tobacco than nonvictims of IPV (p<.001) (Crane, Hawes, & Weinberger, 
2013).  A similar finding was noted in a smaller study of 489 rural, pregnant Appalachian 
women experiencing IPV who were also more likely to abuse both tobacco and alcohol (Gentry 
& Bailey, 2014). After adjusting for confounding, researchers also noted that women 
experiencing IPV were more than twice as likely to smoke both before and during pregnancy 
(OR 2.1 and 2.6 respectively) (Cheng, Salimi, Terplan, & Chisholm, 2015). In addition, a meta-
analysis of data from the Behavioral Risk Factor Surveillance System (BRFSS) demonstrated 
that pregnant women experiencing IPV, receiving Medicaid, who had other children in the home, 
and who reported poor health, were more likely to smoke when compared to women not 
experiencing IPV, not on Medicaid, and those reporting better health (Caleyachetty, Echouoffo-
Tcheugui, Stephenson, & Meunnig, 2002).  Other studies not examining IPV also contribute to 
understanding maternal and fetal complications related to tobacco use in pregnancy. 
 Tobacco Statistics in Pregnancy. According to 2011 Pregnancy Risk Assessment and 
Monitoring System (PRAMS), at least 10% of women used tobacco during the last three months 
of their pregnancy, and while up to 55% of women who smoked prior to pregnancy quit smoking 
 
 
35 
 
during pregnancy, approximately 40% of women will resume smoking within six months of 
delivery. It is estimated that between 12-20% of Tennessee women smoke, and if this prevalence 
were reduced by 1%, the birth of 1,300 low-birth weight infants would be prevented reducing 
hospital expenditures for infant care by $21 million each year (Tennessee Department of Health 
[TNDOH], n.d.).  
 Tobacco Outcomes from Use in Pregnancy. According to the American College of 
Obstetricians and Gynecologists (2013), changes in the fetal placenta due to the influence of 
nicotine from tobacco use during pregnancy causes vasoconstriction of blood vessels, and 
decreases the amount of oxygen and nutrients available to a growing baby.  As a result, babies 
born to mothers that smoke during pregnancy are at higher risk for low-birth weight and 
prematurity (ACOG, 2013; CDC, 2014a; Einarson & Riordan, 2009; Hammoud et al., 2005).   
Studies of tobacco use in pregnancy have also noted that women who smoke are twice as likely 
to develop PROM and placental abruption (OR 2.37 and 2.61 respectively) (Kitsantas & 
Christopher, 2013).  A meta-analysis of studies from 1966-2008 involving tobacco use and 
pregnancy found a 1.2-3.6 relative risk of infertility, a 1.5-2.5 relative risk of ectopic pregnancy, 
a 20-80% higher risk of miscarriage, a 1.2-1.3 increased risk of cleft lip or palate, and a 2.0-3.0 
relative risk of Sudden Infant Death Syndrome (SIDS) (Einarson & Riordan, 2009). 
 Another subset of literature evaluates concurrent cannabis and tobacco use in pregnancy.  
These studies are in support of the contention that cannabis users are also more likely to abuse 
tobacco in pregnancy (Gray et al., 2010; Huizink & Mulder, 2006). It can be difficult, however, 
to exclusively relate the effects of tobacco versus cannabis use to specific pregnancy 
complications because women who smoke may also use cannabis with other illicit substances 
during pregnancy (ACOG, 2015; Jaques et al., 2014). Any illicit substance used during 
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pregnancy can, therefore, be dangerous to both mother and unborn child.  Evidence supports the 
contention that substance abuse can both be an outcome of IPV, or possibly place women at risk 
for IPV, or affect decision-making to seek care for a pregnancy (WHO, 2011). 
 While the identification of potential associations between IPV and maternal substance 
abuse are important to gain understanding of such covariates in this phenomena, it is also 
important to utilize validated assessment tools to both screen for and identify IPV in pregnant 
women. Screening for IPV in pregnancy is important because this presents a unique opportunity 
for repeated patient assessments and provider conversations to occur.  Women may not show 
physical signs of injury due to IPV or may attempt to conceal abusive behavior, and it is for this 
reason that providers must be vigilant to other potential red flags by carefully reviewing medical 
histories, observing behaviors of pregnant women and their partners, and asking direct questions 
(Deshpande & Lewis-O’Connor, 2013).  Several tools currently exist to screen women for IPV in 
pregnancy, which can assist providers when a woman’s level of comfort may prevent direct 
divulgence of existing IPV or at-risk behaviors by a current intimate partner.  
Assessments of IPV in Pregnancy 
Women Abuse Screening Tool (WAST) 
 The WAST (Appendix A) was originally developed by Brown et al (1996) as a tool to be 
used by family practice physicians to assist in the identification of historical physical and 
emotional abuse in their patient populations. The original 7-item scale was expanded later to 
include an eighth question to assess for any kind of sexual abuse (Brown et al., 2000). Its initial 
evaluation demonstrated a reliability of ±=.95, and the single structure factor design for the 
WAST accounted for 85% of the total variance in responses (Brown et al., 1996).  
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  WAST Scoring and Cut-Offs. The first question of the WAST asked the participant to 
respond to the question, “In general, how would you describe your relationship?” which is then 
scored with a cutoff score of one given to the most positive response of  “a lot of tension” and 
zero being assigned to the other response (Brown, 1996) .  The second question asked the 
participant to respond to the question, “Do you and your partner work out arguments with great 
difficulty, some difficulty, or no difficulty?” to which they must respond with “often”, “seldom”, 
or “never”;  (Brown, 1996). The remaining six questions ask for frequency of feeling and 
experiences based on a score of two (“often”), a score of one (“sometimes”), or a score of zero 
(“never”) (Brown, 1996).  The range of scores for the eight-item tool is, therefore, zero to 
sixteen.  Few studies have shown definitive findings for establishing a global cut-off for this tool.  
A study of 240 Indonesian women used a cut-off score of 13 with low sensitivity (41.6%) but 
high specificity (96.8%); a score of 10 increased sensitivity (84.9%), but decreased specificity 
(61%). 
 The efficacy of the WAST has been evaluated in settings other than family practice and 
in other language translations.  A study of pregnant patients seen for orthopedic fractures and 
screened for IPV validated the WAST against the Partner Violence Screen (PVS), and found the 
WAST to be superior to the PVS in identifying IPV in this patient population (37.2% vs. 27.7% 
respectively) (Sprague et al., 2012).  A multi-center study of family practice, OB-GYN, and 
emergency departments supported the efficacy of screening with the WAST tool, and the 
specificity for identifying IPV in the women screened was 89% (MacMillan et al., 2009). A 
cross-sectional study translated the WAST into Icelandic, verified the translated tool for 
retention of meaning and cultural validity and sensitivity, and found it had a reliability of 75.1% 
in identifying IPV in married women and a reliability of 75.5% in identifying IPV in unmarried 
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women in the study sample (Svavarsdottir & Orlysgdottir, 2009). Similarly, the French 
translation of the WAST and WAST-SF demonstrated high reliability (0.95), construct and 
discriminant validity, and also correctly classified 100% of nonabused women and 78.7% of 
abused pregnant women (Brown et al., 2001).  
Hurt, Insult, Threaten, and Scream Tool (HITS) 
 The HITS (Appendix B) was originally developed for use as a screen for violence in the 
family practice setting and is widely used as a screen for IPV in pregnancy (Sherin et al., 1998). 
The HITS was validated against the Conflict Tactics Scale (CTS) (Sherin et al., 1998), and 
validation against the CTS was again performed during the TIPS study.  Validation of the HITS 
against the CTS is done because the CTS is considered the gold standard for identification of 
psychological and physical attacks by intimate partner, and it has been used successfully in at 
least 20 countries (Archer, 1999). The HITS had an initial Cronbach•s ±=.80 for internal 
consistency, demonstrated concurrent validity against the Conflict Tactics Scale (CTS) (±=.85), 
and was found to correctly identify IPV in 96% of patients (Sherin et al., 1998). The 4-item 
questionnaire consists of questions that asks the respondent to answer how often a partner 
physically hurts, insults or talks down to, threatens, or screams/curses at them.  The four-item 
questionnaire was expanded later after study validation to include a fifth question to assess for 
sexual injury or coercion (the E-HITS) (Chan, Chan, & Cheung, 2010). The HITS is scored 
using a Likert-type scale that ranges from the most negative response (“never”) with an 
associated score of one, to the most positive response (“frequently”) with an associated score of 
five.    
 HITS Scoring and Cut-offs. A score of ten on the HITS is suggestive as positive for 
identifying IPV (Sherin et al., 1998), but there is limited evaluation of lower cut-off points to 
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potentially capture abuse in participants with scores below ten.  The HITS and E-HITS had 
identical sensitivities (0.75) and specificities (0.83) in a study of 80 Veterans Health 
Administration (VHA) women using a cut-off score of six and seven respectively (Iverson et al., 
2015). Both the HITS and E-HITS were later validated simultaneously in a study of 290 
Veteran’s Administration (VA) women, and were found to have identical sensitivities (0.75) and 
similar specificities (0.83 and 0.82 respectively) (Iverson et al., 2015).  The Spanish version of 
the HITS was developed and studied demonstrating a reliability of 0.71, a specificity of 86% and 
sensitivity of 100% when a cut-off score of 5.5 was used (Chen, Rovi, Vega, Jacobs, & Johnson, 
2005).   
Simultaneous Use of WAST and HITS 
 Comparisons of the WAST and HITS in an all-pregnant population for the purpose of 
identifying IPV and co-variates has not been documented to date.  Simultaneous use of the 
WAST and HITS in other studies, however, has been noted.  In a sample of 202 Hispanic women 
in a Spanish-predominant clinic setting, the WAST and HITS (English and Spanish versions) 
showed similar intercorrelation (0.76) and reliability (0.78) (p<.001) when administered 
simultaneously to assess for the presence of IPV (Chen et al., 2005).  Another study of 523 
predominantly minority women in a family practice setting demonstrated a Cronbach•s ±=.79 for 
the HITS and ±=.80 for the WAST, with correlations of 0.77 and 0.81 respectively (p<.001) 
(Chen et al., 2007). The WAST and HITS are then recommended for accurate assessment of IPV 
in pregnancy, and have shown consistency in reliability, sensitivity, and specificity in individual 
and joint evaluations of these assessment tools. 
 Identification of factors that may predict IPV is important when planning care and 
treatment for pregnant women.  IPV in pregnancy may also be influenced by psychological 
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factors within the mother or the relationship such as the presence, absence or quality of social 
support, low or high self-esteem, and low or high personal stress.  In order to assess for the 
potential relationship of social support, self-esteem, and stress when IPV is present in pregnancy, 
the use of a validated psychological assessment tool is recommended. 
Psychological Screening When IPV is Present in Pregnancy 
The Prenatal Psychological Profile (PPP) 
 The PPP (Appendix C) has ten questions derived from the Rosenberg Self-Esteem Scale 
(1965).  Questions to evaluate pregnancy stress were added from the Support Behaviors 
Inventory (Brown, 1986), and eleven questions evaluating the impact of social support on 
pregnancy were taken from the Daily Hassles Scale (Kanner, Coyne, Shaefer, & Lazarus, 1981).  
The PPP makes an assumption of a behavioral correlation between psychological factors and 
pregnancy (Curry, Burton, & Fields, 1998), and is utilized both independent of, and as an adjunct 
to assessment of IPV in pregnancy.   
 PPP Scoring and Cut-Offs. Scores for self-esteem and stress range from 11-44, and 
scores for social support range from 11-66. In general, higher scores are associated with higher 
levels of stress, social support, and self-esteem, and scores are then totaled and typically 
recorded continuously for each study participant.  There are no validated studies that suggest a 
certain score to be more indicative of high or low levels of stress, social support, or self-esteem, 
and evaluation of mean scores for these indicators allow researchers to make inferences 
regarding the study sample under evaluation. 
 PPP and IPV Validation Studies. A randomized control trial (RCT) of 1,000 pregnant 
women utilized the PPP concurrently with IPV risk screening, and women reporting high stress, 
low self-esteem, and low social support scores were also more likely to experience physical 
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abuse during pregnancy (Bullock et al., 2006).  Another study of 1,522 pregnant women 
screened with the PPP identified a 3-4 times increased odds ratio of stress in pregnancy, and a 7-
10 times increased odds ratio of depression and panic disorder when IPV was present (Woods, 
Melville, Guo, Fan, & Gavin, 2010). In addition, those women with high levels of psychosocial 
stress were three times more likely to be victims of IPV (OR=3.3) (Woods, et al., 2010).  The 
PPP is, therefore, a well validated assessment tool for determining psychosocial factors that may 
have an association with IPV in pregnancy. 
 Psychosocial factors and substance abuse may be factors that are associated with IPV in 
pregnancy.  As previously noted, maternal alcohol abuse may place women at risk for IPV both 
before and during pregnancy.  It is not sufficient, therefore, to assess for substance abuse in 
pregnancy without also assessing for at-risk drinking using a validated assessment tool. 
Tolerance, Annoyance, Cut-Down, Eye Opener Screening Tool (T-ACE) 
 Alcohol risk drinking is measured via self-report on the T-ACE Screening Tool 
(Appendix D) for pregnancy (Sokol, 1988).  This four-question tool is designed to be 
administered at the first prenatal visit to identify those women engaged in risk drinking in 
pregnancy that could harm a developing fetus (Sokol, 1988). Each of the four questions is 
dichotomously scored with a score of one representing the most positive response. Scores range 
from 0-4 with a score of two being predictive of alcohol risk drinking. 
Validation of the T-ACE Assessment Tool 
 The T-ACE was validated against the Tolerance, Worried, Eye-Opener, Amnesia, and 
Cut-Down (TWEAK) alcohol screening tool, and was shown to have a good positive predictive 
value (0.54) with a strong sensitivity of 93 for a score of two or higher, and a sensitivity of 100 
for scores of three or higher for identifying at-risk drinking in pregnancy (Sarkar, Einarson, & 
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Koren, 2010).  Further validation of the T-ACE against the Michigan Alcoholism Screening Test 
(MAST) and the Cut-Down, Annoyed, Guilty, and Eye-Opener (CAGE) tool demonstrated the 
highest sensitivity of the three tools (0.69) for identifying risk drinking in pregnancy (Chang, 
2001). When compared to the Short Michigan Alcoholism Screening Test (SMAST), the Alcohol 
Use Disorders Identification Test (AUDIT), and standard medical record review, the T-ACE also 
had the highest sensitivity (0.892) among the three alcohol screening methods (Chang, 2001). 
 Studies that have examined the T-ACE alone have not concurrently assessed for the 
presence of IPV.  Other studies not using IPV as a covariate, however, have demonstrated the 
efficacy of the T-ACE in predicting risk drinking during pregnancy.  The T-ACE has also been 
translated into other languages and has been used internationally. For example, the T-ACE was 
administered via telephone to 3,099 pregnant Brazilian women in their native language, and it 
identified 94.7% of risk drinking in women indicating a positive response to the first question on 
the tool (Williams, Nkombo, Nkodia, Leonardson, & Burd, 2013).  Predicting 
neurodevelopmental outcomes in infants was supported using the T-ACE during pregnancy in 75 
African-American inner-city women; however, this study was small with a known high 
percentage of alcohol ingestion before conception (Chiodo, Sokol, Delaney-Black, Janisse, & 
Hannigan, 2010).  Maternal alcohol use in pregnancy was not associated with poor social support 
in a study of 200 women (p=0.22), but use of the T-ACE in this study sample did accurately 
identify early pregnancy drinking as a predictor of subsequent drinking (p<.0001) (McNamara, 
Orav, Wilkins-Haug, & Chang, 2006). Strong evidence of specificity and sensitivity, as well as 
validation against other alcohol screening instruments for pregnancy, supports the use of T-ACE 
in identifying pregnancy risk drinking, which may also assist in predicting IPV in pregnancy. 
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 Assessments of substance abuse, psychological covariates, and alcohol abuse are all 
important in developing predictive models for IPV in pregnancy.  Demographic variables may 
also demonstrate statistical influence or confounding effects for these variables, or they may 
themselves provide insight into the occurrence of IPV in the current study sample.  Examining 
the strength of any associations between sociocultural factors such as personal income and 
poverty, education, marital status, parity, pregnancy planning, age and race, may show evidence 
individually or collectively of a relationship to substance and alcohol abuse, and psychological 
covariates in predicting IPV.  
Sociocultural Influences on IPV in Pregnancy 
Income and Poverty in IPV 
 When examining financial stressors, pregnancy is sometimes the central issue of study, 
but often studies of financial stress evaluate the experience of IPV in the entire life cycle of 
women. A further extension of IPV that may affect pregnancy includes financial IPV through the 
deprivation of basic financial resources in an attempt by the abuser to keep pregnant women 
trapped in the relationship (Romans, Forte, Cohen, DuMont, & Hyman, 2007). A small 
qualitative study of 50 pregnant women experiencing IPV supported this contention, and 
reported that 96% of women in the study sample were actively experiencing stress centered 
around inadequate finances to maintain household utilities, food, or to obtain transportation 
(Bhandari et al., 2008).   
 Financial stressors may or may not improve when women choose to leave an abusive 
relationship.  A large study of predominantly African-American pregnant women found that 
women experiencing IPV were more likely to be unemployed, living under the federal poverty 
line, and receiving public assistance (Li et al., 2010).  In a similar population, Cha and Masho 
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(2014) found that these women were also largely Medicaid recipients.  Similar income, levels of 
poverty, and being recipients of state health insurance programs, were also noted among 
pregnant Mexican-American women experiencing IPV (Jackson et al., 2015).  Low-income 
women were found to benefit from a variety of public and private financial resources after 
leaving an abusive partner when compared to women in higher income brackets (p<.05) (Sonis 
& Langer, 2008). A similar study, however, found middle-income pregnant women benefited 
more from reporting and leaving abusive partners (Kiss et al, 2012). This study was also able to 
demonstrate that women living in middle-range depravity neighborhoods were almost twice as 
likely to experience IPV (OR=1.94), and were greater than three times as likely to experience 
IPV if a male partner was unemployed (OR=3.41) (Kiss et al., 2012). 
Marital Status and IPV 
 The literature is limited when attempting to predict or explain IPV in terms of marital 
status, and often pregnancy status is not used as part of inclusion criteria.  An extensive multi-
site study of military families found that women experiencing physical abuse (OR 1.2) and/or 
emotional abuse (OR 1.3) were more likely to be married (Foran, Slep, Heyman, Linkh, & 
Whitworth, 2011); age and pregnancy status were not documented in this assessment of IPV.  A 
smaller study of Norwegian women without inclusion of pregnancy status found no statistical 
difference between types of IPV (psychological, physical, and sexual) and marital status, but 
married women were statistically more likely to experience psychological abuse than separated 
or divorced women (p=.048) (Vatnar & Bjørkly, 2012).  A study of pregnant Chinese women 
also noted a higher significance for physical IPV and any type of IPV violence in married 
women (Ç2 = 0.018 and 0.002 respectively), but a major limitation of this study was that 98% of 
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the sample was married, which did not allow a diversified study for marital status (Chan et al., 
2011). 
Unplanned Pregnancy and IPV 
 Unintended pregnancy can be the result of sexual or physical IPV.  When sexual IPV 
includes rape, pregnancy can be an unintended consequence of sexual violence, (Gao, Paterson, 
Carter, & Lusitini, 2007; Gazmarian et al., 1995; Goodwin et al., 2000; Pallitto & O’Campo, 
2004), and unintended pregnancy in the presence of IPV can be the impetus to pursue elective 
abortion.  Several studies have also substantiated the finding that all forms of IPV place women 
at higher risk for unintended or unwanted pregnancies (Gao, Paterson, Carter, & Lusitini, 2007; 
Gazmarian et al., 1995; Goodwin et al., 2000; Pallitto & O’Campo, 2004). Unplanned pregnancy 
was statistically associated with IPV in a study of Hispanic during pregnancy (p=0.0196), but 
lack of pregnancy planning was also correlated with being Protestant, having low income, and 
engaging in alcohol abuse (Okada, Hoga, Borges, Alburquerque, & Belli, 2015).  Hispanic 
women experiencing physical and sexual IPV in another study were noted to be greater than 
three times as likely to have unintended pregnancy (OR=3.31), and were twice as likely to 
experience more severe forms of physical abuse (OR=2.17) (Cripe et al., 2008). 
 Pregnancy outcomes as a result of an unplanned pregnancy have also been examined in 
the literature.  One large study of women experiencing IPV found that between 8-10% had an 
unplanned pregnancy as a result of sexual IPV, and 27-46% of these pregnancies resulted in 
elective abortion (Ismayilova & El-Bassel, 2014).  Women presenting to a family planning clinic 
for elective abortion were found to be three times more likely to have experienced sexual, 
physical, or psychological abuse in the past year (p<0.0001) (Bourassa & Bérubé, 2007). A 
meta-analysis of 74 studies in which women had a termination of pregnancy and at least one 
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form of IPV found them to be more likely to have been raped, sexually assaulted, had 
contraceptive sabotage by their partner, or were coerced into pregnancy termination; they were 
almost three times as likely to experience IPV as a result of concealed pregnancy termination as 
well (OR=2.97) (Hall et al., 2014). 
Parity and IPV 
 The association between number of pregnancy (parity) and IPV has not been explored 
individually in the literature.  Parity is often noted in IPV studies descriptively, but its relevance 
and importance to IPV has not been well established. Researchers in one study observed that 
when two or more pregnancies had occurred, all women in a multi-racial analysis were more 
likely to experience IPV (OR 1.93) (Palmetto, Davidson, Breitbart, & Rickert, 2013). An 
examination of uni- and bi-directional violence found that when compared to nulliparous or 
those women with only one pregnancy, African-American women with two or more pregnancies 
were more likely to experience bidirectional violence in a relationship (OR 2.21) (Palmetto et al., 
2013).   An investigation of IPV with parity greater than two has not been evaluated in the 
literature.  Engaging in sexual activity to achieve a first or subsequent pregnancy in an attempt to 
gain respite from physical IPV was noted in a small qualitative study (Edin & Nilsson, 2013). A 
final study noted that adolescent women who experienced IPV within three months of delivering 
an infant were almost twice as likely to become pregnant again (p<.01) (Ranari & Weimann, 
2007). 
Education and IPV 
 Maternal level of achieved education is rarely evaluated as a sole determinant in the 
development or perpetuation of IPV.  Instead, the literature may address maternal education as 
part of a multi-level analysis of this phenomenon.  One large study determined that women with 
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lower levels of education experiencing IPV were more likely to terminate a pregnancy (Antai & 
Adaji, 2012).  Another large study of Indian women found that more years of education was 
positively correlated with greater acceptance of their mistreatment (p<0.05) (Boyle, Georgiades, 
Cullen, & Racine, 2009), but pregnancy was not evaluated as part of this study.  A smaller study 
conducted in Florida (FL) and Massachusetts (MA) found that pregnant women with less than a 
high school education were the highest predictor group for both current abuse (p<.001) and 
abuse during pregnancy (p=.050) (Bohn, Tebben, & Campbell, 2004).  IPV was also directly 
correlated with women obtaining an average of 0.5 fewer years of educational achievement over 
time (p<.05) (Adams, Greeson, Kennedy, & Tolman, 2013); however, pregnancy was not a 
factor in this study, and the central focus was IPV that occurred in adolescence.  Further, an 
additional study of women evaluated prenatally and in the postpartum period found that women 
with 12 years or less of attained education were more likely to report physical and emotional 
abuse (Crude OR 3.02) (Gartland, Hemphill, Hegarty, & Brown, 2011).  
Age and IPV 
 IPV can occur in women of any age, but it is more prevalent in women in their 
reproductive years (ACOG, 2012a). Literature examining the relationship between age and IPV 
is diverse, and often examines its relationship to IPV, mental illness, or maladaptive behaviors 
later in life.  Generally, studies involving pregnancy and IPV either define age descriptively, or 
adjust for age when examining another correlate under observation. A direct relationship was 
established between women exposed to parental abuse early in life and the subsequent transition 
to severe IPV in adulthood (p<.05) without mention of whether these effects were also possibly 
related to pregnancy (Smith, Ireland, Park, Elwyn, & Thornberry, 2011). Other studies have 
asserted that young women (ages 18-25) report all forms of IPV in both pregnancy and pre-
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conception more often than do older women (Li et al., 2010; O’Donnell, Agronick, Duran, 
Myint-U, & Stueve, 2009).  In a Canadian study, younger women were more likely to experience 
both single incident IPV (OR = 11.75) and multiple incidents of IPV (OR=10.98), but this study 
did not reference this increased risk against pregnancy (Romans et al., 2007).  Finally, age was 
not a correlation among 320 Mexican-American pregnant women for IPV both before and during 
pregnancy, with marital status being a stronger predictor of IPV in the study model (Jackson et 
al., 2015). 
Race and IPV 
 Cultural norms and mores are often divergent when describing relationships between men 
and women.  These variations and differences often place women in certain cultures more at risk 
for IPV due to a greater acceptance of such violence, or as a perceived right of husbands or 
partners in a male-dominated society (ACOG, 2012).  According to the World Health 
Organization (WHO), women in societies where family honor, sexual purity, male entitlement, 
or those with weak legal sanctions, place women at high risk for IPV or IPV-related homicide 
(2014). 
 The relevance of race as a predictor of IPV has been studied in various cultural venues, 
but few studies have exclusively examined race as a primary variant in determining possible 
causes of IPV in pregnancy. Pregnant Chinese women were found to be more at risk for IPV in 
relationships after adjusting for age, education, marital status, and income, when social 
desirability, in-law conflict, jealousy, or male dominance were prevalent (OR 2.459, p<.01) 
(Chan et al., 2011). A study examining differences in monoracial and interracial couples found 
that interracial couples and monoracial black couples reported higher incidence of IPV (p<.05, 
p<.01), whether married or cohabiting as compared with dating couples (p<.01) after adjusting 
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for age, education, and income; pregnancy was not a co-variant in this study (Martin, Cui, Ueno, 
& Fincham, 2013).  A multiple ethnicity study of preconception and prenatal IPV found that 
blacks, Hispanics, and non-Hispanic who had low income, less years of achieved education, and 
who were single, experienced higher incidences of both types of IPV when compared with white 
study participants (55.7% vs. 44.3%) (Cha & Masho, 2014). An examination of multiple races 
using the Collaborative Psychiatric Epidemiology Surveys (CPES) found that African-American 
women experienced physical IPV most often (OR 1.191), followed by Latinas and whites, with 
Asian women experiencing IPV least often; age and lower levels of financial security were also 
associated with IPV in Latina and African-Americans, but no notation of pregnancy as a further 
explanatory variable was noted in this study (Cho, 2012).  Similar results were mirrored in an 
IPV prevalence in Texas women of multiple races receiving public primary health care 
(McFarlane, Groff, O’Brien, & Watson, 2005). A final study of Hispanic women in California 
found that women abused as children and those with historical IPV were 25 times more likely to 
be abused during pregnancy; however, lower levels of achieved education and younger were also 
associated with increased incidence of IPV (Castro, Peek-Asa, García, Ruiz, & Kraus, 2003).  
Current Project 
 Attempts to determine causal pathways for IPV have demonstrated many possible 
relationships in the course of this type of partner violence.  Studies examining IPV in pregnancy 
have explored prevalence in women, the perpetrator of violence, and the effects of such violence 
on subsequent generations.  Multivariate analysis of covariates of that may predict IPV by 
examining the influence of stress, social support, self-esteem, substance abuse, and alcohol abuse 
on the likelihood of current or historical IPV in pregnancy has not been explored in the literature.  
Further exploration of IPV predictive factors in pregnant women living in rural communities 
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such as Appalachia that have a high incidence of certain types of substance abuse has been 
explored minimally.  The importance of this type of evaluation can assist in developing predictor 
models for IPV in pregnancy in order to develop better screening methods for providers.  A 
further medical and public health imperative can assist in the development of models and care 
protocols that will assist providers in gaining skills and increased comfort when screening for 
historical or current IPV in pregnancy. The purpose of the current study is to explore the 
prevalence of current and historical IPV in pregnant women in Appalachia and compare to the 
rates of IPV crime reported in the State of Tennessee and in the U.S. (Aim 1). Aim 2 will explore 
various sociocultural influences on psychological and substance abuse factors against current and 
historical abuse in an attempt to predict the phenomenon of IPV in this unique population.  
Finally, Aim 3 will include those factors that are statistically significant from Aim 2 to develop a 
final predictive model for current and historical IPV during pregnancy in the study population. 
Research Aims and Hypotheses 
 Aim 1.  To examine the prevalence of historical IPV as reported in a clinical setting 
among pregnant Appalachian women from the TIPS study sample in contrast to historical IPV 
crime victimization rates for counties in the Appalachian region of Tennessee and in the U.S.   
Aim 1.1 – Determine the prevalence of any type of current (HITS) or historical (WAST) IPV 
victimization rates in the TIPS sample. 
Aim 1.2 – Compare and contrast historical IPV victimization rate prevalence (WAST) in an 
Appalachian sample to county level data in Tennessee utilizing the TNCrimeOnline database for 
2007-2012. 
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Aim 1.3 – Compare and contrast historical IPV victimization rate prevalence (WAST) in an 
Appalachian sample to the United States using U.S. Bureau of Justice IPV data from the 
National Crime Victimization Survey for 2007-2012. 
 Aim 2. Examine psychological, substance abuse, and sociocultural predictors in historical 
and/or current IPV during pregnancy, and compare to non-IPV pregnant women through the 
development of three subcategories from the TIPS study sample illustrating historical IPV alone, 
current and historical IPV combined, and no presence of IPV. 
Aim 2.1 – Determine the independent effect of self-esteem after controlling for income, parity, 
planned pregnancy, age, marital status, race, and education, on predicting IPV.  
Aim 2.2 – Determine the independent effect of social support after controlling for income, parity, 
planned pregnancy, age, marital status, race, and education on predicting IPV.  
Aim 2.3 – Determine the independent effect of stress after controlling for income, parity, 
planned pregnancy, age, marital status, race, and education on predicting IPV.  
Aim 2.4 – Determine the independent effect of any type of substance abuse after controlling for 
income, parity, planned pregnancy, age, marital status, race, and education on predicting IPV.  
Aim 2.5 – Determine the independent effect of alcohol abuse after controlling for income, parity, 
planned pregnancy, age, marital status, race, and education, on predicting IPV. 
 Aim 3.  To examine the joint effects of psychological, substance abuse, and sociocultural 
covariates in predicting IPV. 
Aim 3.1 – Examine statistically significant predictors of IPV from Aim 2 in a multivariate 
analysis. 
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CHAPTER 3 
METHODS 
 Substance abuse, alcohol abuse, sociocultural factors, and psychological factors such as 
stress, social support, and self-esteem have not been explored in one study as predictors of 
current or historical IPV in pregnancy. This unique area of study is important in order to develop 
best practices in public health for screening and planning interventions for women experiencing 
IPV before and during pregnancy.  Examining these IPV factors and their application to an 
Appalachian sample of pregnant women can also assist providers to better understanding the 
phenomena of IPV in this region. 
Database Content Description 
 In 2007, a $1.4-million-dollar grant was awarded by the Tennessee Governor’s Office of 
Child Care Coordination (GOCCC) established in 2004 by then-governor Philip Bredesen.  The 
GOCCC, under the Department of Children’s Services, has been recognized as a leader in 
preventative efforts for infant mortality and substance abuse with the goal of improving health 
outcomes for children and families in Tennessee (Cousins, 2009). The parent grant for the 
current investigation was funded by this Office.  Under the direction of Principal Investigator 
Beth Bailey, PhD, the Tennessee Intervention for Pregnant Smokers (TIPS) program was 
focused on facilitating smoking cessation interventions for pregnant women.  Institutional 
Review Board (IRB) approval for the study was obtained from East Tennessee State University 
(ETSU)/Veteran’s Administration (VA), and is included as Appendix E.  Data were collected in 
two phases over a four-year period, and selected data from TIPS are used for the current study.  
Phase I was conducted from July, 2007, and continued until July, 2012.  Phase II was conducted 
from August 2010, through June, 2012. 
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 Study participants were recruited from five prenatal practices in rural South-Central 
Appalachia. All of the practice locations accepted Medicaid patients with no imposed limitations 
or quota, which resulted in a sample population with low average socioeconomic status. During 
Phase I, participants were recruited over a four-year period from January 2008 to December 
2011. All women entering prenatal care at the five practices during the study period were 
initially eligible following confirmation of a positive pregnancy test.  Women who were non-
English speaking, those with significant cognitive impairments, or those currently incarcerated 
were excluded from study participation.   
 At the first prenatal visit, the study was explained by a project staff member, and 
informed consent for participation in the study was obtained at that time (Appendix F). Over 
90% of women invited agreed to participate, resulting in a final sample of 1,063 pregnant 
women. Prenatal care was initiated by participants at varying weeks of gestation, with the 
majority of women beginning prenatal care in the second trimester. Participants received a small 
monetary incentive for completing the research interview, which took up to an hour to complete. 
Participating women completed the initial research interview at or within two weeks of their first 
prenatal visit. During participant interviews, demographic information and screenings for mental 
health and social issues were obtained. At delivery, prenatal and hospital delivery records were 
reviewed for pregnancy sequelae and birth outcomes.  
 Various clinical tools were administered to study participants in either Phase I and/or 
Phase II in order to assess tobacco use, substance or alcohol abuse, psychological stress, and 
IPV. Some of the tools utilized included the Women Abuse Screening Tool (WAST) (Brown, 
Lent, Schmidt, & Sas, 1996), the Prenatal Psychological Profile (PPP) (Curry, et al., 1998), the 
Hurt, Insult, Threat Scream Tool for Intimate Partner Violence Screening (HITS) (Sherin, 
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Sinacore, Zitter, & Shakil, 1998), and the T-ACE (Sokol, Martier, & Ager, 1989) for alcohol risk 
screening in pregnancy. All of the above screening tests and tools are utilized for the current 
study. 
Aim 1 Variables 
 The overall objective of Aim 1 is to examine the prevalence of historical and current IPV 
as reported in a clinical setting among pregnant Appalachian women from the TIPS study 
sample.  Prevalence of historical IPV will then be contrasted to historical IPV crime 
victimization rates for Carter, Greene, Hawkins, Johnson, Sullivan, Unicoi, and Washington 
counties in the Appalachian Region of Tennessee and against IPV crime victimization rates in 
the U.S. to assist in understanding IPV phenomena in pregnant women in the TIPS study sample. 
Study results anticipate that the TIPS numbers for IPV will be higher because they are self-report 
of IPV, while the IPV victimization crime rates are the actual reports of perpetrated crimes.  IPV 
is a very underestimated crime because many women do not report this crime, fearing that 
family, friends, or even law enforcement will not believe it is actually occurring (Black et al., 
2011).  The Bureau of Justice (2014) estimated that approximately 2.4 per 1,000 U.S. women 
aged 12 or older experienced IPV, but only between five and fifteen percent actually reported its 
occurrence.   
 In order to describe historical and current IPV crime victimization rates in the study 
population, IPV assessment tools were administered to study participants.  Historical IPV 
victimization rates were obtained from the TNCrimeOnline database for Sullivan, Washington, 
Carter, Johnson, Unicoi, Greene, and Hawkins counties in the State of Tennessee to mirror the 
six counties represented in the TIPS sample.  Bureau of Justice historical IPV victimization data 
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for the U.S. in general was also collected to describe and contrast with historical IPV 
victimization rates in the State of TN data and the TIPS study sample. 
Current and Historical IPV 
 In order to determine pre-pregnancy and intrapartum domestic violence, two well 
validated screening tools, the WAST and the HITS, were utilized and administered to study 
participants.  These assessments were completed at the initial prenatal clinical visit in the first 
trimester and again in the third trimester.  For the purpose of this study, initial data from the first 
trimester screening utilizing the WAST and HITS was used to establish a baseline for IPV 
victimization rates. 
 Use of WAST to Describe Historical IPV Before Pregnancy.  The full eight-question 
WAST tool was utilized to assess historical IPV in the study sample.  Participants used self-
report to describe their experience with physical, psychological, sexual, and emotional abuse 
prior to becoming pregnant.  Responses were then scored and totaled with a possible score of 0-
16 entered as a continuous variable. 
 As previously noted, few studies have shown evidence for establishing a global cut-off 
score for this tool to definitively describe positive IPV.  A cut-off point that demonstrates 
specificity for positive IPV, though not well established, has suggested that a score of two out of 
a range of zero to four on one of the first two questions (also called the WAST short form or 
WAST-SF) is suggestive as positive for identifying IPV risk because these two questions 
globally frame conflict in the relationship (Cheung & Liebschultz, 2002).  The first question asks 
the respondent to note in general how they describe their relationships in terms of tension, with a 
score of one given to a response of “a lot of tension, and zero being applied to responses of 
“some tension” or “no tension” (Brown et al., 1996).  The second question asks the respondent to 
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note how they and their partner work out arguments in terms of difficulty, and a score of one is 
applied to a response of “great difficulty”, and zero is applied to responses of “some difficulty” 
or “no difficulty”.  For questions 3-8, a score of two is applied to a response of “often” (Brown et 
al., 1996).  To evaluate a score of two as being positive for historical IPV for the study sample, 
the WAST variable in the dataset was dichotomously recoded with 1=scores greater than or 
equal to two (positive), and 0=scores less than two (negative) to capture responses of “a lot of 
tension” on question one, “great difficulty” on question two, and “often” on any of questions 3-8.   
 Use of HITS to Describe Current IPV in Pregnancy. The HITS four-question tool was 
utilized to assess current IPV during pregnancy in the study sample. A fifth question was added 
in 2010 to extend the HITS tool to also assess sexual abuse during pregnancy for a more 
comprehensive assessment of IPV (the E-HITS) (Chan, Chan, & Cheung, 2010), and a modified 
version of the E-HITS was used for the TIPS study.  Participants used self-report to describe 
their experience with physical, psychological, sexual, and emotional abuse prior to becoming 
pregnant. Responses were then scored and totaled for a possible score of 5-25.  Current IPV in 
pregnancy is descriptively reported only for Aim 1.1, and is not used for comparison against 
TNCrimeOnline or U.S. IPV victimization rates because IPV victimization rates in these 
databases are retrospectively reported reflecting historical IPV only. 
 The HITS was validated against the Conflict Tactics Scale (CTS) (Sherin et al., 1998), 
and validation against the CTS was again performed during the TIPS study.  A score of ten on 
the HITS is suggestive as positive for identifying IPV (Sherin et al., 1998), but there is limited 
evaluation of lower cut-off points to potentially capture abuse in participants with scores below 
ten.  When validated against the CTS, the HITS and E-HITS had identical sensitivities (0.75) and 
similar specificities (0.83 and 0.82) in a study of 80 Veterans Health Administration (VHA) 
 
 
57 
 
women using a cut-off score of six and seven respectively (Iverson et al., 2015). To evaluate a 
score of seven as being positive for current IPV in pregnancy for the study sample, the HITS 
variable was dichotomously recoded with 0=HITS scores less than seven, and 1=scores greater 
than or equal to seven in order to capture a response of “sometimes” on any of the five questions. 
 Tennessee Bureau of Investigation Historical IPV Victimization Rates. 
Operationalizing a definition for historical IPV victimization rates is an important step in 
attempting to contrast historical IPV in the study sample. Under the Uniform Crime Reporting 
Program (UCR), “agencies submit crime reports monthly to a centralized crime records facility 
within their state…and the state UCR Program then forwards the data, using uniform offense 
definitions, to the FBI’s national UCR Program” (U.S. Department of Justice, 2014, p. 1). The 
operational definition for historical IPV victimization rate for the State of Tennessee is, 
therefore, obtained from U.S. Bureau of Justice terms and definitions in order to standardize 
crime reporting data from state to state against national crime data. Victimization rates are 
operationally defined as the number of persons present during an incident and for high frequency 
repeat victimizations (or series victimizations) (Truman & Morgan, 2014). 
 TN crime data is collected via statistics from each law enforcement division from each of 
its 95 counties.  Historical IPV victimization rates are compiled into a central comprehensive 
database entitled TNCrimeOnline, which is then made available to the public for informational 
and reporting purposes (Tennessee Bureau of Investigation [TBI], n.d.).  Tutorials illustrate the 
use of the reporting tool and assist consumers to compile reports by selecting criteria of interest, 
dates of interest, and variables of interest, which are then generated according to the user’s 
specifications into a table or chart format.  The tables can then be printed or exported for use in 
reports, research or presentations. TBI data from 2007-2012 historical IPV victimization rates for 
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females aged 12 or older in Sullivan, Washington, Carter, Johnson, Unicoi, and Hancock 
counties were used with WAST historical IPV victimization rates from the same period to 
describe and contrast prevalence rates of historical IPV in the TIPS study sample to county level 
data in the TNCrimeOnline database. 
 U.S. Bureau of Justice (BOJ) Historical IPV Victimization Data. National U.S. data 
on domestic violence is collected annually from the National Crime Victimization Survey 
(NCVS).  The NCVS is administered to households annually to both report frequency, 
consequences, and characteristics of domestic violence in the U.S (Bureau of Justice Statistics, 
n.d.)  Annual reports and summary reports are compiled and made available to the public both on 
the internet and directly from the U.S. Department of Justice website for research and 
informational purposes. BOJ historical IPV victimization rates from 2007-2012 for females aged 
12 or older is used to describe and contrast WAST historical IPV victimization rates in the 
sample against U.S historical IPV victimization rates, which will also be contrasted against TN 
historical IPV victimization data. 
Aim 2 Variables 
 The overall objective of Aim 2 is to examine psychological, substance abuse, and 
sociocultural predictors in historical and/or current IPV during pregnancy, and compare to non-
IPV pregnant women through the development of three subcategories from the TIPS study 
sample illustrating historical IPV alone, current and historical IPV combined, and no presence of 
IPV.  The three categories that will be examined for Aim 2 include those pregnant women in the 
TIPS study sample who are positive for historical IPV only, positive for both historical and 
current IPV in pregnancy, and those that are negative for both historical and current IPV.  
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Variables Used for Analysis of Historical and Current IPV 
 The WAST and HITS variables were dichotomized as described in Aim 1.  The original 
TIPS study variables were recoded and renamed as follows: “WASTDiss” to represent historical 
IPV; and “HITSDiss” to represent current IPV.  These recoded variables were used to create the 
following IPV subcategories: WASTDiss positive only, WASTDiss and HITSDiss positive, and 
neither WASTDiss or HITSDiss positive.  The prevalence of current IPV only in pregnancy was 
low in the study sample (n=7) and is, therefore, excluded from Aim 2. Elimination of this group 
of women from analysis is based on findings of the National Intimate Partner and Sexual 
Violence (NISVS), which consistently demonstrates that women experiencing physical or sexual 
violence report violence in the previous 12 months, with only rare occurrences of IPV beginning 
only when a pregnancy is diagnosed (Brieding et al., 2011). The remaining three subcategories 
will then be computed into a new variable “IPV” for frequency analysis.  
Pregnancy Psychological Indicators for IPV 
 The Prenatal Psychological Profile (PPP) was utilized to explore maternal stress, the 
presence or absence of social support, and to document high or low self-esteem in the TIPS study 
sample.  During Phase I of the TIPS study, individual participant responses for stress, social 
support, and self-esteem were documented into three separate continuous variables.  The 
variables utilized for this portion of the analysis are “PPP Social Support”, “PPP Self-Esteem, 
and “PPP Stress”.  
Substance Abuse Indicators for IPV 
 Urine drug screens were performed on all women in the TIPS study sample to establish a 
baseline of maternal substance use during pregnancy.  For the purposes of the current study, 
meconium drug screens in infants obtained in approximately one third of the infants born to 
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study participants were not used to confirm maternal self-report or maternal urine drug screens 
due to the small subsample size.  Instead, data obtained from routine prenatal maternal urine 
drug screens (UDS) were dichotomized as “positive” or “negative”, and descriptive information 
for each type of substance detected in the UDS is indicated below. 
 Opiates. Use of opiates was indicated by self-report on the initial TIPS interview, and 
confirmed via maternal urine drug screen.  The TIPS study variable “opiates” was dichotomized 
to indicate the presence or absence of opiate use during pregnancy. 
 Sedatives. Use of sedatives such as benzodiazepines or barbituates was indicated by self-
report on the initial TIPS interview, and confirmed via maternal urine drug screen. The TIPS 
study variables “benzodiazepine” and “barbituate” were dichotomized to indicate the presence or 
absence of sedative use during pregnancy. 
 Methadone/Suboxone. Use of methadone or suboxone to treat opiate addiction in 
pregnancy was indicated by self-report on the initial TIPS interview, and confirmed via maternal 
urine drug screen. The TIPS study variables “methadone” and “suboxone” were dichotomized to 
indicate the presence or absence of methadone or suboxone use during pregnancy. 
 Marijuana. Use of marijuana was indicated by self-report on the initial TIPS interview, 
and confirmed via maternal urine drug screen. The TIPS study variable “marijuana” was 
dichotomized to indicate the presence or absence of marijuana use during pregnancy. 
 Alcohol. Use of alcohol was indicated by self-report on the Tolerance, Annoyance, Cut-
Down and Eye-Opener (T-ACE) Screening Tool for pregnancy (Sokol, 1988).  This four-
question tool is designed to be administered at the first prenatal visit to identify those women 
who may engage in risk drinking during pregnancy. The TIPS study variable indicated the self-
report score from the T-ACE for alcohol use during pregnancy, which ranged from 0-5 with a 
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score of two being predictive of alcohol risk drinking.  Total scores for each study participant 
were then listed in a continuous variable.  For the purpose of the current study, the original 
continuous T-ACE variable was dichotomized to classify maternal risk drinking with 0=T-ACE 
score less than two and 1=T-ACE scores greater than or equal to two, and was renamed “T-
ACE1”. 
Covariates Used as Controls for IPV  
 It is not known whether sociocultural influences are predictive of IPV in pregnancy when 
factors such as high or low stress, positive or negative social support, high or low self-esteem, 
substance and alcohol abuse are also present.  It is also not known whether individual influences 
of sociocultural variables such as income, marital status, age, race, parity, education, and 
whether a pregnancy was or was not planned may have a statistical relationship with stress, 
social support, self-esteem, and substance or alcohol abuse in the study sample.  The strength of 
the association of these covariates must then be evaluated in a univariate analysis in order to 
develop a predictive model for IPV in pregnancy in Aim 3. 
 Income. TIPS study participants were asked to provide a self-report of their total 
household income, and this information was recorded into the variable “income”, with ten ranges 
categorizing income for each study participant.  As previously noted, a large percentage of 
clients were Medicaid recipients.  Income ranged from less than $5,000 to greater than $100,000.  
In order to reflect the 2014 median income in Tennessee for 2014 of $44,298 (United States 
Census, 2014), the categorical “income” variable was dichotomized with 0=income less than or 
equal to $44,298 and 1= income greater than $44,298 and renamed “Income1”. 
 Number of Pregnancy.  Parity was assessed via the question “what number of 
pregnancy is this”, and this information was validated by review of prenatal records.  Data from 
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this variable was collected in a continuous format. There was a wide range in parity in the study 
population (1-23 pregnancies), with a mean number of pregnancies being equal to two. The 
majority of the sample had between one and five pregnancies historically (N=1,009), and the 
average number of children per family in the US is less than five (Vespa, Lewis, & Kreider, 
2013).  As a result, this variable was dichotomized where 0=l-5 pregnancies, and 1= greater than 
5 pregnancies and renamed “NumPreg1”.  
 Planned Pregnancy.  Study participants were asked to provide a self-report of whether 
or not the current pregnancy was planned.  Women responded “yes” or “no” to the question, 
“was this pregnancy planned”, and the data was this dichotomized into the variable “pregnancy 
planned”. 
 Age.  Self-report was utilized to answer the question, “how old are you” on an initial 
questionnaire eliciting demographic information (Appendix G).  Age in years was then entered 
as a continuous variable which ranged from 14-44.  For the purpose of the current study, the 
continuous age variable was categorized to reflect ACOG definitions (2015c) of maternal age as 
follows: 1=Adolescent Maternal Age 14-17; 2=Young Maternal Age 18-24; 3=Average Maternal 
Age 25-35; and, 4=Advanced Maternal Age >35. 
 Marital Status. Women in the study were asked to identify their current marital status on 
the demographic questionnaire.  Seven categorical entries were used to code the information 
provided as “married”, “divorced”, “widowed”, “separated”, “separated but living with new 
partner”, “single, never married”, and “single living with partner”.  Six out of the seven 
categories reflected unmarried women, so for the purposes of this study, this information was 
dichotomously coded to 0=single and 1=married.  The new categorical variable was renamed 
“Married1”. 
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 Education. Demographic information asked study participants to indicate “highest level 
of education achieved”.  Completion of grades 3-12 were continuously coded as such, college 
graduates were coded as “16”, completion of graduate school was coded as “20”, and completion 
of doctoral education was coded as “24”. For the purposes of the current study, the education 
variable was dichotomized where 0=less than high school and 1=high school graduate or beyond, 
to reflect Tennessee education categories for US Census (Tennessee QuickFacts, 2014), and is 
renamed “Education1”. 
 Race.  Five categories of race were obtained via participant self-report.  These categories 
included the following: “white”; “black”; “Asian”; “Hispanic”; and “multi-racial”.  The majority 
of the sample self-identified as “white, so for this reason, the original study variable was recoded 
with 0=white, and 1=other, and is renamed “Race1”. 
Aim 3 Variables 
 To determine Aim 3 outcomes, the subgroups created in Aim 1 for current and historical 
IPV will again be utilized in Aim 3.  Maternal psychological indicators for social support, self-
esteem, and stress, as well as substance abuse indicators, that were found to be significant from 
Aim 2 will be used in Aim 3.   
Data Analysis Plan 
Aim 1 
 It is hypothesized that the prevalence of historical IPV victimization rates in the TIPS 
study sample will be higher than TN county level historical IPV victimization rates, and also 
higher than U.S. historical IPV victimization rates. In order to examine this supposition, Aim 1 
will require the determination of prevalence of both historical and current IPV of any type. 
Descriptive statistics were obtained using SPSS® software for WAST (historical) and HITS 
(current).  Six records in the transformed HITS variable “HITSDiss” did not contain information 
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regarding IPV for a final analysis sample of n=1,057.  The transformed WAST variable 
“WASTDiss” contained 44 missing records for a final analysis sample of n=1,019.  For Aims 1.2 
and 1.3, prevalence for historical IPV only (WASTDiss) was then compared to both State of TN 
IPV data (Aim 1.2) and Department of Justice IPV data (Aim1.3). 
 SPSS software were utilized to perform frequency analysis for each of the WASTDiss 
and HITSDiss variables, and frequencies of historical IPV by county in the TIPS sample will 
also be calculated.  Using the total recorded population for Sullivan, Washington, Carter, 
Johnson, Unicoi, and Hancock counties from TNCrimeOnline data for 2007-2012, percentages 
will be calculated to allow for description and contrast of TIPS historical IPV victimization rates 
to TN data for these same counties.  Similarly, the total recorded population for historical IPV 
victimization rates for 2007-2012 from the BOJ database will be utilized to create percentages to 
allow for description and contrast of TIPS historical IPV victimization rates prevalence to U.S. 
rates of historical IPV victimization percent prevalence.   
Aim 2 
 In order to conduct Aim 2, a 2X2 table was assembled using Crosstabs in SPSS® 22 
software using the WASTDiss and HITSDiss variables.  After initially determining prevalence 
for these two variables in Aim 1, three subgroups of historical and current IPV were created.  
The first subgroup divided the sample into those that were WAST positive only (score e  2), the 
second subgroup indicated WAST and HITS positive (scores e  2 on WAST and e  7 on HITS), 
and the third subgroup indicated negative for both WAST and HITS (scores less than 2 on 
WAST and less than 7 on HITS).  
 For Aims 2.1-2.6, it is hypothesized that education and income may exert confounding 
effects when evaluating the independent effect of stress, social support, self-esteem, and 
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substance and alcohol abuse on IPV.  In order to determine the statistical significance of this 
hypothesis, it was necessary to perform ordinal logistic regression using SPSS® Version 22 
software to determine the independent effect of the continuous dependent variables of stress, 
social support, and self-esteem after controlling for independent variables to include income, 
parity, planned pregnancy, age, marital status, and education, to predict IPV. Using ordinal 
logistic regression via SPSS® Version 22 software, the independent effect of the dependent 
categorical variables of individual substances of abuse as described above, and alcohol were 
examined after controlling for independent variables of income, parity, planned pregnancy, age, 
marital status, and education to predict IPV. 
Aim 3 
 It is hypothesized that substance and alcohol abuse, combined with high maternal stress 
and low self-esteem, will be the greatest influences in predicting IPV in pregnancy. The most 
significant independent effects for stress, social support, self-esteem, and substance and alcohol 
abuse analyzed in Aim 2.1-2.6 will be analyzed using multinomial logistic regression for SPSS® 
22 software to construct a final predictive model of current and historical IPV influences in 
pregnancy.  A final backward stepwise multinomial logistic regression will be completed to 
examine potential moderation and interaction effects.  
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CHAPTER 4 
RESULTS 
Aim 1 
Aim 1.1 
 The purpose of Aim 1.1 was to determine the prevalence of any type of historical 
(WAST) IPV or current (HITS) IPV victimization in the TIPS sample.  A full sample of analysis 
(N=1,016) examined the historical IPV variable (WASTDiss) and the current IPV variable 
(HITSDiss) for frequency, and a crosstab analysis of historic and current IPV yielded a sample of 
1,016 after adjustment for missing cases (N=47).  Positive prevalence of current and/or historical 
IPV as well as negative percentages for the TIPS study sample is represented in Table 1. 
Table 1 
   Historical and/or Current IPV Prevalence in TIPS Sample 
 
IPV Type Positive N 
% Prevalence 
Positive 
% Prevalence     
Negative  
Crosstabs 
      Historical IPV Only 354 34.83 65.17 
   Current IPV Only 7 0.07 99.93 
   Historic and Current IPV 165 16.20 83.80 
   Neither Historic Nor Current 497 48.90 51.10 
 
Aim 1.2 
The purpose of Aim 1.2 was to compare and contrast historical IPV victimization rate 
prevalence (WAST) in an Appalachian sample to county level crime data in Tennessee utilizing 
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the TNCrimeOnline database for 2007-2012.  To address this aim, the TIPS study sample was 
divided by county of residence, and the prevalence of IPV was determined at the county level.  
Pregnant women with current IPV were excluded from this analysis because the data available 
for comparison is retrospective in nature, and does not represent a real-time analysis of current 
IPV, but rather reports rates of IPV victimization that have occurred in the past. 
The sample consisted of 1,016 women after adjustment for missing data, and the age 
range of the sample was 14-44.  Of this number, Appalachian pregnant women reporting 
historical IPV (WASTDiss) were evaluated using the SPSS® Crosstabs feature to determine a 
subsample by county of residence.  Those participants not residing in Carter, Greene, Hawkins, 
Johnson, Sullivan, Unicoi, or Washington Counties, to include those pregnant women residing in 
Virginia, were eliminated from analysis to determine a final sample (N=908).  TIPS sample 
historical IPV percent prevalence by TN County was then calculated (Table 2). 
Table 2 
   Historical or Current IPV Prevalence in Study Sample 
 TN County Subjects Reporting Total # TIPS Subjects  % 
  Historical IPV N=514 By County N=908  Prevalence 
Carter 39 79 49.4 
Greene 20 38 52.6 
Hawkins 3 6 50.0 
Johnson 23 40 57.5 
Sullivan 121 266 45.5 
Unicoi 23 36 63.9 
Washington 233 443 52.6 
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 In order to compare and contrast IPV victimization rates to the State of TN, the 
TNCrimeOnline Database was utilized to construct TN data by county for 2007-2012 for female 
victims of historical IPV aged 14-45 to mirror the study period and participant characteristics for 
the sample.  The TNCrimeOnline report was constructed from retrospective data for TN 
historical IPV victimization rates by Carter, Greene, Hawkins, Johnson, Sullivan, Unicoi, and 
Washington counties, and after compiling the data from the public website, the TN data by 
county were exported into an Excel® spreadsheet.  The rates were then converted to percent 
prevalence for comparison to the study sample (Table 3).  The hypothesis that the self-reported 
historical IPV victimization rates for the study sample would be higher than TN reportable 
historical IPV victimization rates was supported based on the available comparison data.  
Table 3 
     Historical IPV Victimization Rates  - TIPS Study Sample vs. TNCrime Online Data 
TN County 
TIPS Sample 
N=514 
% 
Prevalence 
TNCrimeOnline*  
N=15,767 
% 
Prevalence 
 Carter 39 49.4 1211   7.7 
 Greene 20 52.6 2113 13.4 
 Hawkins 3  5.0 1328   8.4 
 Johnson 23 57.5 1150   7.3 
 Sullivan 121 45.5 5406 34.3 
 Unicoi 23 63.9 451   2.7 
 Washington 233 52.6 4108 26.1 
 *Source: Tennessee Bureau of Investigation: Tennessee Crime Online Statistics 
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Aim 1.3 
 The purpose of Aim 1.3 was to compare and contrast historical IPV victimization rate 
prevalence (WAST) in the Appalachian sample to the United States using U.S. BOJ IPV data 
from the National Crime Victimization Survey for 2007-2012.  The number of pregnant women 
in the TIPS study sample reporting historical IPV was first determined via the WASTDiss 
variable (N=505).  To compare and contrast IPV victimization rates to the U.S., BOJ data was 
utilized for 2007-2012 for female victims of historical IPV aged 12 and older to mirror the study 
period and participant characteristics for the sample.  The BOJ report was constructed with 
retrospective data extracted from the National Crime Victimization Survey, and the rates 
published were per 1,000 population.  The hypothesis that the self-reported historical IPV 
victimization rates for the study sample would be higher than U.S. reportable historical IPV 
victimization rates was supported based on the available comparison data (Table 4).  
Table 4 
       Historical IPV Victimization Rates – TIPS Study Sample vs. U.S. Data 
     % Prevalence Rate Per 1000 
     TIPS Study Sample 0.510 510.3 
     US*  0.055 5.5** 
       *Source: Truman & Justice (2014). Nonfatal domestic violence: 2003-2012. U.S. Department of Justice 
**Based on rate per 1000 average -  2007-2012 
     
Aim 2 
Aim 2.1 
 Table 5 provides descriptive statistics for self-esteem, as well as social support (Aim 2.2) 
and stress (Aim 2.3).  The purpose of Aim 2.1 was to determine the independent effect of self- 
esteem after controlling for income, parity, planned pregnancy, age, marital status, race, and 
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Table 5 
     Descriptive Data for Self-Esteem, Social Support, and Stress Variables 
Variable N Range Mean Standard Deviation 
    Lower Upper     
Self-Esteem  1016 11 44 35.6211 5.8710 
Social Support 1016 12 66 52.8101 10.2320 
Stress 1016 11 38 18.8620 5.0660 
 
education, on predicting IPV. Descriptive frequencies for the control variables are presented in 
Table 6.  Univariate and multivariate PLUM models were analyzed using the continuous PPP 
self-esteem variable and the computed IPV variable created with three categories: 1=historical 
IPV positive only; 2=historical and current IPV positive; and, 3=historical and current IPV 
negative (the reference category).  Total self-esteem score data were entered continuously 
(N=1016) with a range of scores from 11-44. 
Table 6 
  Descriptive Frequencies for Control Variables 
  Variable N % of Sample 
Income     
   d$44,298 873 85.9 
   >$44,298 143 14.1 
Parity 
     1-5 Pregnancies 966 95.1 
   >5 Pregnancies 50 4.9 
Planned Pregnancy 
     Yes 331 32.6 
   No 685 67.4 
Age 
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Table 6 (continued)   
   Adolescent Maternal Age (14-17) 57 5.6 
   Young Maternal Age (18-24) 513 50.5 
   Average Maternal Age (25-35) 385 37.9 
   Advanced Maternal Age (>35) 61 6 
Marital Status 
     Married 577 56.8 
   Single 439 43.2 
Race 
     White 954 93.9 
   Other 62 6.1 
Education 
     Less Than High School 187 18.4 
   High School or Above 829 81.6 
 
The independent effect of self-esteem to predict an association with IPV was significant 
in both the univariate and multivariate analyses (Table 7).  When examined independently, for 
every one- unit increase in self-esteem, there is a 9.5% increase in the odds of historical IPV only 
(Category 1) (OR=1.095, 95% CI, 5.930-27.378), a statistically significant effect, Wald Ç2(1) = 
42.531, p<.001, when compared with pregnant women who reported neither historical or current 
IPV.  A one-unit decrease in self-esteem also was associated with a 90.9% decrease in the odds 
of current and historical IPV (Category 2) (OR=0.091, 95% CI 0.070-0.112), also a statistically 
significant effect, Wald Ç2(1) = 85.714, p<.001. Similar results were noted when controlling for 
income, parity, planned pregnancy, age, marital status, race, and education.  When self-esteem 
was analyzed with control variables, for every one unit increase in self-esteem there was an 8.4% 
increase in the odds of historical IPV (Category 1) (OR=1.084, 95% CI, 0.974-8.985), Wald 
Ç2(1) = 3.661, p=.056, when compared with pregnant women who reported neither historical nor 
current IPV.  However, the CI includes one which indicates insufficient evidence to conclude 
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that the groups are significantly statistically different.  After analysis with control variables, a 
one-unit decrease in self-esteem was associated with an 92% decrease in odds of current and 
historical IPV (Category 2) (OR= 0.08, 95% CI, 0.58-0.103) when compared to women reporting 
historical only and historical and current IPV, also a statistically significant effect, Wald Ç2(1) = 
10.476, p=.001.  The full model with control variables was, however, only able to explain 10.8% 
(Cox and Snell) and 12.4% (Nagelkerke) of the variance in predicting IPV, and the overall 
goodness-of-fit for the model is small (Pearson=.038, Deviance=.011), leading to rejection of the 
null that the model is a good fit. 
Table 7 
            Ordinal Regression for Independent Effect of Self-Esteem to Predict IPV 
    
      Univariate   
 95% 
CI      Multivariate      95% CI  
 
Variable N OR Wald p Lower Upper OR Wald p Lower Upper 
 
Historical IPV Only 346 12.742 42.531 <.001 5.93 27.398 2.958 3.661 0.056 0.974 8.985 
 
      Self-Esteem 1016 1.095 67.884 <.001 1.072 1.119 1.084 50.728 <.001 1.060 1.108 
 
      Pregnancy Not Planned 
     
  1.777 10.753 0.001 1.260 2.505 
 
      Pregnancy Planned* 
     
  - - - - - 
       Married 
     
  1.093 0.263 0.608 0.778 1.535 
 
      Single* 
     
  - - - - - 
      Adolescent Maternal Age 
     
  1.519 0.815 0.367 0.613 3.761 
 
     Young Maternal Age 
     
  1.260 0.493 0.483 0.661 2.401 
 
     Average Maternal Age 
     
  0.936 0.041 0.839 0.496 1.767 
 
     Advanced Maternal Age* 
     
  - - - - - 
      Less Than High School 
     
  1.394 2.470 0.116 0.921 2.111 
 
     High School or Beyond* 
     
  - - - - - 
       Less Than $44,298 
     
  1.291 1.097 0.295 0.800 2.083 
 
      More Than $44,298* 
     
  - - - - - 
       White 
     
  1.015 0.002 0.963 0.547 1.884 
 
      Other* 
     
  - - - - - 
       1-5 Pregnancies 
     
  1.468 1.160 0.282 0.730 2.954 
 
      > 5 Pregnancies*             -  - - - - 
 
Historical and Current IPV 164 26.283 68.236 <.001 12.101 57.085 6.307 10.476 0.001 2.068 19.237 
 
      Self-Esteem 1016 0.091 85.714 <.001 0.070 0.112 0.080 71.177 <.001 0.058 0.103 
 
      Pregnancy Not Planned 
     
  1.607 4.163 0.041 1.019 2.535 
 
      Pregnancy Planned* 
     
  - - - - - 
       Married 
     
  1.384 2.071 0.150 0.889 2.156 
 
      Single* 
     
  - - - - - 
      Adolescent Maternal Age 
     
  1.589 0.490 0.484 0.434 5.812 
 
 
 
73 
 
Table 7 (continued)             
     Young Maternal Age 
     
  1.930 1.752 0.186 0.729 5.107 
 
     Average Maternal Age 
     
  1.501 0.675 0.411 0.570 3.958 
 
     Advanced Maternal Age* 
     
  - - - - - 
 
     Less Than High School 
     
  1.341 1.255 0.263 0.803 2.241 
 
     High School or Beyond* 
     
  - - - - - 
 
      Less Than $44,298 
     
  1.683 2.021 0.155 0.821 3.448 
 
      More Than $44,298* 
     
  - - - - - 
 
      White 
     
  1.271 0.372 0.542 0.589 2.743 
 
      Other* 
     
  - - - - - 
 
      1-5 Pregnancies 
     
  2.159 2.333 0.127 0.804 5.798 
 
      >5 Pregnancies*              - - - - - 
 *Reference Category 
             
Aim 2.2 
The purpose of Aim 2.2 was to determine the independent effect of social support after 
controlling for income, parity, planned pregnancy, age, marital status, race, and education, on 
predicting IPV.  Univariate and multivariate PLUM models were analyzed using the continuous 
PPP social support variable and the computed IPV variable.  Total social support score data were 
entered continuously (N=1053) with a range of scores between 12 and 66. 
The independent effect of social support to predict an association with IPV was 
significant in the univariate and multivariate analyses (see Table 8).  When examined 
independently, a one-unit increase in social support was associated with a 5.1% increased odds 
for historical IPV (Category 1) (OR=1.051, 95% CI, 1.034-1.068), a statistically significant 
effect, Wald Ç2 (1) = 77.56, p<.001, when compared with pregnant women who reported neither 
historical nor current IPV.  A one-unit decrease in social support was also associated with 51% 
decreased odds of current and historical IPV (Category 2) (OR=0.49, 95% CI, 0.37-0.62), also a 
statistically significant effect, Wald Ç2(1) = 161.429, p<.001. Dissimilar results were noted when 
controlling for income, parity, planned pregnancy, age, marital status, race, and education.  
When social support was analyzed with control variables, a one-unit decrease in social support 
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was also associated with a 95.7% decrease in odds for current and historical IPV only (Category 
2) (OR=0.043, 95% CI, 0.031-0.056) when compared with pregnant women who reported 
neither historical nor current IPV.  The full model with control variables was, however, only able 
to explain 10.8% (Cox and Snell) and 12.4% (Nagelkerke) of the variance in predicting IPV, and 
the overall goodness-of-fit for the model is small (Pearson=.036, Deviance=.068), leading to 
rejection of the null that the model is a good fit. 
Table 8 
           Ordinal Regression for Independent Effect of Social Support to Predict IPV 
       Univariate    95% CI    Multivariate      95% CI  
Variable 
      
N OR Wald p Lower Upper OR Wald p Lower Upper 
Historical IPV Only 346 6.566 32.551 <.001 3.44 12.533 1.627 0.864 0.353 0.583 4.537 
      Social Support 1016 1.051 77.564 <.001 1.034 1.068 1.044 62.31 <.001 1.031 1.057 
      Pregnancy Not Planned 
     
  1.716 9.369 0.002 1.214 2.425 
      Pregnancy Planned* 
     
  - - - - - 
      Married 
     
  1.168 0.797 0.372 0.831 1.642 
      Single* 
     
  - - - - - 
     Adolescent Maternal Age 
     
  1.281 0.279 0.597 0.511 3.208 
     Young Maternal Age 
     
  1.177 0.240 0.624 0.612 2.264 
     Average Maternal Age 
     
  0.908 0.240 0.769 0.476 1.732 
     Advanced Maternal Age* 
     
  - - - - - 
     Less Than High School 
     
  1.557 4.263 0.039 1.023 2.370 
     High School or Beyond* 
     
  - - - - - 
      Less Than $44,298 
     
  1.305 1.186 0.276 0.808 2.106 
      More Than $44,298* 
     
  - - - - - 
      White 
     
  0.916 0.078 0.780 0.495 1.694 
      Other* 
     
  - - - - - 
      1-5 Pregnancies 
     
  1.708 2.174 0.140 0.838 3.481 
      >5 Pregnancies*             -  - - - - 
Historical and Current IPV 164 13.421 60.158 <.001 6.963 25.868 3.436 5.531 0.019 1.228 9.612 
      Social Support 1016 0.490 161.429 <.001 0.370 0.620 0.043 146.154 <.001 0.031 0.056 
      Pregnancy Not Planned 
     
  1.552 3.069 0.080 0.949 2.537 
      Pregnancy Planned* 
     
  - - - - - 
      Married 
     
  1.533 3.103 0.078 0.953 2.466 
      Single* 
     
  - - - - - 
     Adolescent Maternal Age 
     
  1.559 0.380 0.538 0.379 6.408 
     Young Maternal Age 
     
  2.245 2.229 0.135 0.776 6.489 
     Average Maternal Age 
     
  1.764 1.106 0.293 0.612 5.082 
     Advanced Maternal Age* 
     
  - - - - - 
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Table 8 (continued)            
     Less Than High School 
     
  1.301 0.848 0.357 0.743 2.278 
     High School or Beyond* 
     
  - - - - - 
      Less Than $44,298 
     
  1.377 0.698 0.404 0.650 2.920 
      More Than $44,298* 
     
  - - - - - 
      White 
     
  0.972 0.004 0.948 0.413 2.289 
      Other* 
     
  - - - - - 
      1-5 Pregnancies 
     
  3.029 4.386 0.036 1.074 8.548 
      >5 Pregnancies*             -  - - - - 
*Reference Category 
 
           Aim 2.3 
The purpose of Aim 2.3 was to determine the independent effect of stress after controlling for 
income, parity, planned pregnancy, age, marital status, race, and education, on predicting IPV.  
Univariate and multivariate PLUM models were analyzed using the continuous PPP stress 
variable and the computed IPV variable. Total stress score data were entered continuously 
(N=1062) with a score range between 11 and 38. 
The independent effect of stress to predict an association with IPV was significant in both 
the univariate and multivariate analyses (Table 9).  When examined independently, a one-unit 
decrease in stress was associated with an 11.2% decreased odds of historical IPV only (Category 
1) (OR=0.888, 95% CI, 0.866-0.911), a statistically significant effect, Wald Ç2(1) = 94.282, 
p<.001, when compared with pregnant women who reported neither historical nor current IPV.  
A one-unit decrease in stress was also associated with an 88.2% decreased odds of current and 
historical IPV (Category 2) (OR=0.118, 95% CI, 0.014-0.193), also a statistically significant 
effect, Wald Ç2(1) = 177.687, p<.001. Similar results were noted when controlling for income, 
parity, planned pregnancy, age, marital status, race, and education.  When stress was analyzed 
with control variables, a one-unit decrease in stress was associated with a 10.6% decreased odds 
of historical IPV only (Category 1) (OR=0.894, 95% CI, 0.871-0.918), a statistically significant 
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effect, Wald Ç2(1) = 84.48, p<.001, and a one-unit increase in stress was also associated with a 
37.3% increased odds of historical and current IPV (Category 2) (OR=1.373, 95% CI, 1.308-
1.441), a statistically significant effect, Wald Ç2(1) = 164.895, p<.001 when compared with 
pregnant women who reported neither historical nor current IPV.  The full model with control 
variables was, however, only able to explain 13.1% (Cox and Snell) and 15.1% (Nagelkerke) of 
the variance in predicting IPV, and the overall goodness-of-fit for the model is small 
(Pearson=.001, Deviance=.007), leading to rejection of the null that the model is a good fit. 
Table 9 
           Ordinal Regression for Independent Effect of Stress to Predict IPV 
          Univariate    95% CI      Multivariate   95% CI  
Variable N OR Wald p Lower Upper OR Wald p Lower Upper 
Historical IPV Only 346 0.051 132.012 <.001 0.031 0.085 0.02 63.286 <.001 0.008 0.53 
      Stress 1016 0.888 94.282 <.001 0.866 0.911 0.894 84.48 <.001 0.871 0.918 
      Pregnancy Not Planned 
     
  1.735 9.612 0.002 1.225 2.458 
      Pregnancy Planned* 
     
  - - - - - 
      Married 
     
  0.984 0.009 0.926 0.694 1.394 
      Single* 
     
  - - - - - 
     Adolescent Maternal Age 
     
  1.799 1.523 0.217 0.708 4.570 
     Young Maternal Age 
     
  1.263 0.470 0.493 0.648 2.464 
     Average Maternal Age 
     
  0.918 0.066 0.798 0.476 1.771 
     Advanced Maternal Age* 
     
  - - - - - 
     Less Than High School 
     
  1.628 5.075 0.024 1.065 2.487 
     High School or Beyond* 
     
  - - - - - 
      Less Than $44,298 
     
  1.317 1.230 0.267 0.810 2.141 
      More Than $44,298* 
     
  - - - - - 
      White 
     
  0.907 0.092 0.761 0.481 1.708 
      Other* 
     
  - - - - - 
      1-5 Pregnancies 
     
  1.774 2.369 0.124 0.855 3.681 
      >5 Pregnancies*             -  - - - - 
Historical and Current IPV 164 0.107 79.583 <.001 0.065 0.174 0.044 41.714 <.001 0.017 0.113 
      Stress 1016 0.118 177.687 <.001 0.014 0.193 1.373 164.895 <.001 1.308 1.441 
      Pregnancy Not Planned 
     
  0.382 2.347 0.125 0.899 2.391 
      Pregnancy Planned* 
     
  - - - - - 
      Married 
     
  1.078 0.094 0.759 0.668 1.738 
      Single* 
     
  - - - - - 
     Adolescent Maternal Age 
     
  3.302 2.754 0.097 0.806 13.536 
     Young Maternal Age 
     
  2.563 2.955 0.086 0.876 7.497 
     Average Maternal Age 
     
  1.665 0.868 0.351 0.570 4.867 
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Table 9 (continued)            
     Advanced Maternal Age* 
     
  - - - - - 
     Less Than High School 
     
  1.505 2.031 0.154 0.858 2.642 
     High School or Beyond* 
     
  - - - - - 
      Less Than $44,298 
     
  1.544 1.240 0.266 0.719 3.315 
      More Than $44,298* 
     
  - - - - - 
      White 
     
  0.977 0.003 0.957 0.413 2.309 
      Other* 
     
  - - - - - 
      1-5 Pregnancies 
     
  3.119 4.417 0.036 1.080 9.011 
      >5 Pregnancies*              - - - - - 
*Reference Category 
 
           Aim 2.4  
The purpose of Aim 2.4 was to determine the independent effect of any type of substance 
abuse after controlling for income, parity, planned pregnancy, age, marital status, race, and 
education on predicting IPV.  To broadly describe the independent effect of substance abuse for 
the sample population, marijuana, opiates, methadone/suboxone, and sedatives/benzodiazepines 
were analyzed separately. Univariate and multivariate PLUM models were analyzed using each 
of the substance abuse variables and the computed IPV variable.  Frequency data for the 
substance abuse variables is noted in Table 10. 
Table 10 
  Descriptive Frequencies for Variables Assessing Substance Abuse in Pregnancy  
Variable N Percent of Sample 
Marijuana 1016 
    Yes 200 19.7 
   No 816 80.3 
Opiates 1016 
    Yes 169 16.6 
   No 847 83.4 
Methadone/Suboxone 1016 
    Yes 33 3.2 
   No 983 96.8 
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Table 10 (continued)   
Sedatives 1016 
    Yes 169 16.6 
   No 847 83.4 
Alcohol (Via T-ACE Assessment) 1016 
    Score ≥2 282 27.8 
   Score <2 734 72.2 
 
Marijuana. Approximately 25% of pregnant women who reported historical and current 
IPV in the study sample used marijuana (n=89).  The independent effect of marijuana to predict 
an association with IPV demonstrated significance in the multivariate analyses only (Table 11).  
When examined independently, not using marijuana during pregnancy was associated with a 
29.6% decrease in odds of historical and current IPV only (Category 2) (OR=0.704, 95% CI, 
0.409-0.999), a statistically significant effect, Wald Ç2(1) = 27.133, p<.001, when compared with 
pregnant women who did smoke marijuana and reported neither historical nor current IPV.  
Similar results were noted when controlling for income, parity, planned pregnancy, age, marital 
status, race, and education.  When marijuana was analyzed with control variables, not using 
marijuana during pregnancy was associated with a 52.7% decreased odds of historical and 
current IPV only (Category 2) (OR=0.473, 95% CI, 0.166-0.780), a statistically significant 
effect, Wald Ç2(1) = 12.827, p<.001, when compared with pregnant women who did smoke 
marijuana and reported neither historical or current IPV.  The full model with control variables 
was, however, only able to explain 6.6% (Cox and Snell) and 7.6% (Nagelkerke) of the variance 
in predicting IPV, and the overall goodness-of-fit for the model is large (Pearson=.226, 
Deviance=.073), leading to acceptance of the null that the model is a good fit. 
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Table 11 
Ordinal Regression for Independent Effect of Marijuana to Predict IPV 
  
      Univariate   
 95% 
CI      Multivariate        95% CI  
Variable N OR Wald p Lower Upper OR Wald p Lower Upper 
Historical IPV Only 346 0.905 0.541 0.462 0.693 1.181 0.279 1.612 0.204 0.119 0.654 
      Marijuana 1016 2.022 22.756 <0.001 1.505 2.716 1.604 10.356 0.001 1.180 2.181 
      Pregnancy Not Planned 
     
  1.861 13.411 <0.001 1.335 2.594 
      Pregnancy Planned* 
     
  - - - - - 
      Married 
     
  1.158 0.759 0.384 0.833 1.610 
      Single* 
     
  - - - - - 
     Adolescent Maternal Age 
     
  1.146 0.092 0.762 0.474 2.768 
     Young Maternal Age 
     
  1.000 0.000 1.000 0.534 1.874 
     Average Maternal Age 
     
  0.872 0.188 0.664 0.469 1.620 
     Advanced Maternal Age* 
     
  - - - - - 
     Less Than High School 
     
  1.480 3.646 0.056 0.990 2.213 
     High School or Beyond* 
     
  - - - - - 
      Less Than $44,298 
     
  1.442 2.377 0.123 0.906 2.295 
      More Than $44,298* 
     
  - - - - - 
      White 
     
  0.852 0.270 0.603 0.466 1.558 
      Other* 
     
  - - - - - 
      1-5 Pregnancies 
     
  1.176 0.225 0.635 0.603 2.293 
     >5 Pregnancies*             -  - - - - 
Historical and Current IPV 164 1.803 18.398 <0.001 1.377 2.361 0.578 8.645 0.003 0.247 1.348 
      Marijuana 1016 0.704 27.133 <0.001 0.409 0.999 0.473 12.827 <0.001 0.166 0.780 
      Pregnancy Not Planned 
     
  1.754 6.265 0.012 1.130 2.722 
      Pregnancy Planned* 
     
  - - - - - 
      Married 
     
  1.500 3.392 0.066 0.974 2.308 
      Single* 
     
  - - - - - 
     Adolescent Maternal Age 
     
  1.082 0.015 0.903 0.307 3.808 
     Young Maternal Age 
     
  1.428 0.550 0.458 0.557 3.666 
     Average Maternal Age 
     
  1.410 0.508 0.476 0.548 3.628 
     Advanced Maternal Age* 
     
  - - - - - 
     Less Than High School 
     
  1.441 2.091 0.148 0.878 2.366 
     High School or Beyond* 
     
  - - - - - 
      Less Than $44,298 
     
  1.973 3.625 0.057 0.980 3.973 
      More Than $44,298* 
     
  - - - - - 
      White 
     
  0.966 0.008 0.927 0.460 2.029 
      Other* 
     
  
           1-5 Pregnancies 
     
  1.176 0.799 0.371 0.599 3.934 
     >5 Pregnancies*             -  - - - - 
*Reference Category 
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 Opiates. Of those pregnant women reporting historical IPV only, 16.6% used opiates, 
and 23% of those reporting historical and current IPV also reported opiate use.  The independent 
effect of taking any type of opiate and its ability to predict an association with IPV demonstrated 
mixed significance in the univariate and multivariate analyses (Table 12).  When examined 
independently, use of any type of opiate during pregnancy did not have a statistically significant 
effect for historical only (p=0.211) (Category 1); however, historical only IPV was significant 
(p=0.002).  Use of opiates during pregnancy was significant (p=0.008) (Category 2) when 
compared with pregnant women who did not use opiates and reported neither historical nor 
current IPV; however, its effect on historical and current IPV was not significant (p=0.131).  
Dissimilar results were noted when controlling for income, parity, planned pregnancy, age, 
marital status, race, and education.  When opiates were analyzed with control variables, not using 
opiates in pregnancy was associated with a 38.2% decreased in odds of historical and current 
IPV (Category 2) (OR=0.618, 95% CI, 0.389-0.982) (Wald Ç2(1) = 4.158, p=0.041) when 
compared with pregnant women who did use opiates and reported neither historical nor current 
IPV.  Use of opiates in pregnancy did not have a statistically significant effect for historical only 
IPV (Category 1) (p=0.613) in the multivariate analysis; however, historical IPV was significant 
(p<0.001). The full model with controlling variables was, however, only able to explain 5.7% 
(Cox and Snell) and 6.6% (Nagelkerke) of the variance in predicting IPV; however, the overall 
goodness-of-fit for the model is large (Pearson=.584, Deviance=.317), leading to acceptance of 
the null that the model is a good fit. 
Table 12 
           Ordinal Regression for Independent Effect of Opiates to Predict IPV 
   
      
Univariat
e   
 95% 
CI      
Multivariat
e   
  95% 
CI    
Variable N OR Wald p 
Lowe
r 
Uppe
r OR Wald p Lower 
Uppe
r 
Historical IPV Only 346 
0.63
4 9.538 0.002 0.475 0.847 0.185 16.024 
<.00
1 0.081 0.423 
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      Opiates 
101
6 
1.26
2 1.568 0.211 0.924 1.724 1.127 0.255 0.613 0.813 1.563 
Table 12 
(continued)            
      Pregnancy Not Planned 
     
  1.900 14.468 
<.00
1 1.365 2.644 
      Pregnancy Planned* 
     
  - - - - - 
      Married 
     
  1.228 1.524 0.217 0.886 1.701 
      Single* 
     
  - - - - - 
     Adolescent Maternal Age 
     
  1.178 0.133 0.716 0.488 2.843 
     Young Maternal Age 
     
  1.037 0.013 0.909 0.555 1.937 
     Average Maternal Age 
     
  0.894 0.127 0.721 0.482 1.657 
     Advanced Maternal Age* 
     
  - - - - - 
     Less Than High School 
     
  1.554 4.675 0.031 1.042 2.316 
     High School or Beyond* 
     
  - - - - - 
      Less Than $44,298 
     
  1.510 3.036 0.081 0.950 2.400 
      More Than $44,298* 
     
  - - - - - 
      White 
     
  0.854 0.267 0.605 0.469 1.554 
      Other* 
     
  - - - - - 
      1-5 Pregnancies 
     
  1.213 0.319 0.572 0.620 2.371 
      >5 Pregnancies*             -  - - - - 
Historical and Current IPV 164 
1.24
8 2.281 0.131 0.936 1.665 0.380 5.318 0.021 0.167 0.865 
      Opiates 
101
6 
0.90
3 7.124 0.008 0.607 1.342 0.618 4.158 0.041 0.389 0.982 
      Pregnancy Not Planned 
     
  1.774 6.563 0.010 1.144 2.751 
      Pregnancy Planned* 
     
  - - - - - 
      Married 
     
  1.598 4.635 0.031 1.043 2.449 
      Single* 
     
  - - - - - 
     Adolescent Maternal Age 
     
  1.214 0.091 0.763 0.345 4.273 
     Young Maternal Age 
     
  1.530 0.786 0.375 0.598 3.915 
     Average Maternal Age 
     
  1.455 0.608 0.436 0.567 3.735 
     Advanced Maternal Age* 
     
  - - - - - 
     Less Than High School 
     
  1.511 2.699 0.100 0.923 2.471 
     High School or Beyond* 
     
  - - - - - 
      Less Than $44,298 
     
  2.057 4.109 0.043 1.024 4.131 
      More Than $44,298* 
     
  - - - - - 
      White 
     
  1.000 0.000 0.999 0.479 2.088 
      Other* 
     
  - - - - - 
      1-5 Pregnancies 
     
  1.708 1.234 0.267 0.664 4.390 
      >5 Pregnancies*             -  - - - - 
*Reference Category 
            
 Methadone/Suboxone. Of those pregnant women reporting historical or current IPV, 
3.2% reported methadone or suboxone use.  The independent effect of taking either methadone 
 
 
82 
 
or suboxone and their ability to predict an association with IPV did not demonstrate significance 
in the univariate or multivariate analyses (Table 13).  When examined independently, using 
either methadone or suboxone during pregnancy did not have a statistically significant effect on 
historical IPV in the univariate or multivariate analyses (p=0.385, p=0.622 respectively) when 
compared with pregnant women who did not use methadone or suboxone and reported neither 
historical nor current IPV; however, historical IPV was significant in both analyses (p=0.001, 
p=0.005 respectively).  Similar results were noted when controlling for income, parity, planned 
pregnancy, age, marital status, race, and education.  When methadone and suboxone was 
analyzed with control variables, using either methadone or suboxone was statistically significant 
in the univariate and multivariate analysis for historical or current IPV (Category 2) (p=0.011, 
p=0.023 respectively) however, historical and current IPV was not significant in either analysis 
p=0.201, p=0.133 respectively).   The full model with controlling variables was only able to 
explain 5.7% (Cox and Snell) and 6.6% (Nagelkerke) of the variance in predicting IPV; 
however, the overall goodness-of-fit for the model is large (Pearson=.265, Deviance=.395), 
leading to acceptance of the null that the model is a good fit. 
Table 13 
           Ordinal Regression for Independent Effect of Methadone/Suboxone to Predict IPV 
 
      Univariate   
 95% 
CI      Multivariate      95% CI  
Variable N OR Wald p Lower Upper OR Wald p Lower Upper 
Historical IPV Only 346 0.752 11.052 0.001 0.396 1.43 0.216 7.984 0.005 0.075 0.625 
      Methadone/Suboxone 1016 1.457 0.753 0.385 0.759 2.795 1.263 0.242 0.622 0.638 2.498 
      Pregnancy Not Planned 
     
  1.904 14.604 <.001 1.369 2.650 
      Pregnancy Planned* 
     
  - - - - - 
      Married 
     
  1.226 1.505 0.220 0.885 1.699 
      Single* 
     
  - - - - - 
     Adolescent Maternal Age 
     
  1.162 0.113 0.737 0.483 2.794 
     Young Maternal Age 
     
  1.031 0.009 0.924 0.552 1.925 
     Average Maternal Age 
     
  0.887 0.145 0.703 0.478 1.645 
     Advanced Maternal Age* 
     
  - - - - - 
     Less Than High School 
     
  1.572 4.949 0.026 1.055 2.342 
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     High School or Beyond* 
     
  - - - - - 
      Less Than $44,298 
     
  1.503 2.971 0.085 0.946 2.390 
Table 13 (continued)            
      More Than $44,298* 
     
  - - - - - 
      White 
     
  0.852 0.274 0.601 0.468 1.551 
      Other* 
     
  - - - - - 
      1-5 Pregnancies 
     
  1.190 0.261 0.610 0.611 2.318 
      >5 Pregnancies*             -  - - - - 
Historical and Current IPV 164 1.479 1.635 0.201 0.778 2.813 0.444 2.254 0.133 0.154 1.282 
      Methadone/Suboxone 1016 0.698 6.416 0.011 0.276 1.763 0.295 5.193 0.023 0.119 0.728 
      Pregnancy Not Planned 
     
  1.805 6.965 0.008 1.164 2.799 
      Pregnancy Planned* 
     
  - - - - - 
      Married 
     
  1.578 4.360 0.037 1.028 2.422 
      Single* 
     
  - - - - - 
     Adolescent Maternal Age 
     
  1.094 0.020 0.888 0.313 3.830 
     Young Maternal Age 
     
  1.433 0.586 0.444 0.565 3.685 
     Average Maternal Age 
     
  1.358 0.405 0.524 0.530 3.481 
     Advanced Maternal Age* 
     
  - - - - - 
     Less Than High School 
     
  1.607 3.568 0.059 0.982 2.630 
     High School or Beyond* 
     
  - - - - - 
      Less Than $44,298 
     
  2.012 3.852 0.050 1.001 4.043 
      More Than $44,298* 
     
  - - - - - 
      White 
     
  0.972 0.006 0.940 0.464 2.036 
      Other* 
     
  - - - - - 
      1-5 Pregnancies 
     
  1.531 0.792 0.373 0.599 3.913 
     >5 Pregnancies*              - - - - - 
*Reference Category 
            
 Sedatives/Benzodiazepines. The independent effect of taking any type of sedative or 
benzodiazepine and its ability to predict an association with IPV demonstrated significance in the 
multivariate analysis only (Table 14).  When controlling for income, parity, planned pregnancy, 
age, marital status, race, and education, not using sedatives or benzodiazepines in pregnancy was 
associated with a 41.3% decrease in odds of historical and current IPV only (Category 2) 
(OR=0.587, 95% CI, 0.371-0.928) a statistically significant effect, Wald Ç2(1) = 5.193, p=0.023, 
when compared with pregnant women who did use either sedatives or benzodiazepines and 
reported neither historical nor current IPV.  The full model with controlling variables was only 
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able to explain 5.7% (Cox and Snell) and 6.6% (Nagelkerke) of the variance in predicting IPV; 
however, the overall goodness-of-fit for the model is large (Pearson=.278, Deviance=.115), 
leading to acceptance of the null that the model is a good fit. 
Table 14 
           Ordinal Regression for Independent Effect of Sedatives/Benzodiazepines to Predict IPV 
      Univariate    95% CI      Multivariate      95% CI  
Variable N OR Wald p Lower Upper OR Wald p Lower Upper 
Historical IPV Only 346 0.613 11.052 0.001 0.459 0.818 0.184 16.341 <.001 0.081 0.418 
      Sedatives/Benzodiazepines 1016 1.210 0.753 0.201 0.887 1.653 1.124 0.242 0.622 0.813 1.554 
      Pregnancy Not Planned 
     
  1.906 14.634 <.001 1.370 2.652 
      Pregnancy Planned* 
     
  - - - - - 
      Married 
     
  1.232 1.579 0.209 0.890 1.706 
      Single* 
     
  - - - - - 
     Adolescent Maternal Age 
     
  1.175 0.129 0.720 0.487 2.833 
     Young Maternal Age 
     
  1.043 0.017 0.895 0.558 1.950 
     Average Maternal Age 
     
  0.903 0.105 0.746 0.486 1.676 
     Advanced Maternal Age* 
     
  - - - - - 
     Less Than High School 
     
  1.552 4.632 0.031 1.040 2.315 
     High School or Beyond* 
     
  - - - - - 
      Less Than $44,298 
     
  1.517 3.108 0.078 0.955 2.410 
      More Than $44,298* 
     
  - - - - - 
      White 
     
  0.855 0.262 0.609 0.469 1.557 
      Other* 
     
  - - - - - 
      1-5 Pregnancies 
     
  1.202 0.293 0.589 0.617 2.343 
      >5 Pregnancies*             -  - - - - 
Historical and Current IPV 164 1.206 1.635 0.201 0.905 1.607 0.378 5.457 0.019 0.167 0.855 
      Sedatives/Benzodiazepines 1016 0.906 6.416 0.229 0.610 1.344 0.587 5.193 0.023 0.371 0.928 
      Pregnancy Not Planned 
     
  1.807 7.011 0.008 1.166 2.801 
      Pregnancy Planned* 
     
  - - - - - 
      Married 
     
  1.622 4.935 0.026 1.059 2.484 
      Single* 
     
  - - - - - 
     Adolescent Maternal Age 
     
  1.209 0.087 0.768 0.343 4.255 
     Young Maternal Age 
     
  1.583 0.912 0.340 0.617 4.060 
     Average Maternal Age 
     
  1.535 0.790 0.374 0.597 3.948 
     Advanced Maternal Age* 
     
  - - - - - 
     Less Than High School 
     
  1.479 2.420 0.120 0.903 2.422 
     High School or Beyond* 
     
  - - - - - 
      Less Than $44,298 
     
  2.094 4.321 0.038 1.043 4.204 
      More Than $44,298* 
     
  - - - - - 
      White 
     
  1.010 0.001 0.979 0.483 2.110 
      Other* 
     
  - - - - - 
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      1-5 Pregnancies 
     
  1.605 0.977 0.323 0.628 4.102 
      >5 Pregnancies*             -  - - - - 
Aim 2.5 
 The purpose of Aim 2.5 was to determine the independent effect of alcohol after 
controlling for income, parity, planned pregnancy, age, marital status, race, and education on 
predicting IPV.  As noted earlier, study participants underwent a T-ACE Assessment during their 
initial interview to determine those pregnant women who might engage in risk drinking.  
Univariate and multivariate PLUM models were analyzed using the recoded T-ACE1 variable 
and the computed IPV variable. 
 Use the T-ACE Assessment Tool and a score of two or higher as being predictive for an 
association with at-risk drinking in pregnancy demonstrated that 28.7% (n=98) of those positive 
for at-risk drinking also reported historical IPV.  The independent effect of using alcohol during 
pregnancy and its ability to predict IPV did not demonstrate a significant effect in the univariate 
and multivariate analyses (Table 15).  Alcohol was not a significant effect for historical only IPV 
and historical and current IPV (p=0.113, p=0.107 respectively), but both categories of IPV were 
significant (p<0.001 for each parameter) when compared with pregnant women who did not use 
alcohol and reported neither historical nor current IPV.  The effect of alcohol was significant in 
the univariate analysis for historical and current IPV (p=0.025), but historical and current IPV 
only approached significance (p=0.070), and alcohol did not have significant effect in the 
multivariate analysis for current and historical IPV (p=0.056).  The full model with controlling 
variables was only able to explain 5.9% (Cox and Snell) and 6.8% (Nagelkerke) of the variance 
in predicting IPV; however, the overall goodness-of-fit for the model is large (Pearson=.252, 
Deviance=.109), leading to acceptance of the null that the model is a good fit. 
Table 15 
           Ordinal Regression for Independent Effect of Alcohol to Predict IPV 
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      Univariate    95% CI      Multivariate    95% CI    
Variable N OR Wald p Lower Upper OR Wald p Lower Upper 
Table 15 (continued)            
Historical IPV Only 346 0.622 15.866 <.001 0.492 0.786 0.221 12.882 <.001 0.097 0.504 
      Alcohol 1016 1.267 2.506 0.113 0.970 1.655 1.273 2.605 0.107 0.964 1.682 
      Pregnancy Not Planned 
     
  1.910 14.267 <.001 1.365 2.673 
      Pregnancy Planned* 
     
  - - - - - 
      Married 
     
  1.176 0.889 0.346 0.840 1.646 
      Single* 
     
  - - - - - 
     Adolescent Maternal Age 
     
  1.023 0.002 0.961 0.420 2.488 
     Young Maternal Age 
     
  1.029 0.008 0.930 0.547 1.933 
     Average Maternal Age 
     
  0.858 0.234 0.628 0.460 1.598 
     Advanced Maternal Age* 
     
  - - - - - 
     Less Than High School 
     
  1.696 6.387 0.011 1.126 2.556 
     High School or Beyond* 
     
  - - - - - 
      Less Than $44,298 
     
  1.471 2.618 0.106 0.922 2.347 
      More Than $44,298* 
     
  - - - - - 
      White 
     
  0.878 0.176 0.675 0.479 1.610 
      Other* 
     
  - - - - - 
      1-5 Pregnancies 
     
  1.145 0.155 0.694 0.583 2.248 
      >5 Pregnancies*             -  - - - - 
Historical and Current IPV 164 1.239 3.279 0.070 0.982 1.563 0.461 3.43 0.064 0.203 1.046 
      Alcohol 1016 0.761 5.016 0.025 0.546 1.060 0.671 3.648 0.056 0.446 1.010 
      Pregnancy Not Planned 
     
  0.599 7.091 0.008 1.171 2.830 
      Pregnancy Planned* 
     
  - - - - - 
      Married 
     
  1.821 3.909 0.048 1.004 2.411 
      Single* 
     
  - - - - - 
     Adolescent Maternal Age 
     
  0.984 0.001 0.979 0.280 3.455 
     Young Maternal Age 
     
  1.434 0.560 0.454 0.558 3.682 
     Average Maternal Age 
     
  1.374 0.434 0.510 0.534 3.538 
     Advanced Maternal Age* 
     
  - - - - - 
     Less Than High School 
     
  1.749 4.802 0.028 1.061 2.884 
     High School or Beyond* 
     
  - - - - - 
      Less Than $44,298 
     
  2.098 4.312 0.038 1.042 4.222 
      More Than $44,298* 
     
  - - - - - 
      White 
     
  0.986 0.001 0.971 0.469 2.075 
      Other* 
     
  - - - - - 
      1-5 Pregnancies 
     
  1.855 1.438 0.230 0.676 5.094 
      >5 Pregnancies*                       
*Reference Category 
            
Aim 3 
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 The purpose of Aim 3 was to examine the joint effects of psychological, substance abuse, 
and sociocultural covariates in predicting IPV by examining statistically significant predictors of 
IPV from Aim 2 in a multivariate analysis. The ordinal regression analyses from Aim 2 
demonstrated significance for all of the individual effect variables either for historical IPV only 
(Category 1), for historical and current IPV (Category 2) or both; therefore, self-esteem, social 
support, stress, marijuana, opiates, methadone/suboxone, sedatives/benzodiazepines, and alcohol 
were added to a multinomial regression analysis with backward stepwise evaluation.  As a 
comparison, all independent effect variables from Aim 2 were also evaluated with all controlling 
variables to determine any confounding effects.  The multinomial regression results of these 
analyses are shown in Table 16. 
Table 16 
Multinomial Regression for Predicting Historical & Current IPV 
  Univariate    Multivariate   
Variable OR Wald χ2 p 95% CI OR Wald χ2 p 95% CI 
Historical IPV Only  61.610 <.001    0.007 0.931 
      Self-Esteem 0.956 8.008 0.005 0.927-0.986 0.964 5.067 0.024 0.933-0.995 
     Social Support 0.954 21.633 <.001 0.936-0.973 0.957 17.916 <.001 0.938-0.977 
     Stress 1.134 33.861 <.001 1.087-1.183 1.146 36.52 <.001 1.096-1.198 
     Marijuana 0.509 10.614 0.001 0.340-0.764 0.631 4.534 0.033 0.413-0.964 
     Opiates 1.282 1.184 0.276 0.819-2.007 1.272 1.026 0.311 0.799-2.026 
     Methadone/Suboxone 1.049 0.009 0.925 0.386-2.853 0.968 0.004 0.953 0.328-2.856 
     Sedatives/Benzodiazepines 1.045 0.039 0.843 0.675-1.618 1.025 0.012 0.914 0.652-1.612 
     Alcohol 1.009 0.002 0.961 0.710-1.433 0.967 0.033 0.855 0.673-1.390 
      Pregnancy Not Planned 
   
  1.663 7.353 0.007 1.151-2.401 
      Pregnancy Planned* 
   
  - - - - 
      Married 
   
  0.863 0.591 0.442 0.593-1.257 
      Single* 
   
  - - - - 
     Adolescent Maternal Age 
   
  1.582 0.846 0.358 0.595-4.207 
     Young Maternal Age 
   
  1.454 1.079 0.299 0.717-2.950 
     Average Maternal Age 
   
  0.951 0.02 0.887 0.476-1.900 
     Advanced Maternal Age* 
   
  - - - - 
     Less Than High School 
   
  1.517 3.187 0.074 0.960-2.397 
     High School or Beyond* 
   
  - - - - 
      Less Than $49,000 
   
  1.122 0.202 0.653 0.679-1.854 
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      More Than $49,000* 
   
  - - - - 
      White 
   
  1.056 0.027 0.87 0.547-2.040 
Table 16 (continued)         
      Other* 
   
  - - - - 
      1-5 Pregnancies 
   
  1.924 2.701 0.1 0.882-4.198 
      Greater Than 5 Pregnancies*         -  - - - 
Historical & Current IPV  102.846 <.001    1.551 0.213 
 
      Self-Esteem 0.986 0.022 0.534 0.944-1.030 0.987 0.316 0.574 0.944-1.033 
      Social Support 0.906 61.012 <.001 0.884-0.929 0.905 58.852 <.001 0.882-0.929 
      Stress 1.253 65.262 <.001 1.187-1.324 1.269 67.357 <.001 1.199-1.344 
      Marijuana 0.483 7.252 0.007 0.285-0.820 0.646 2.398 0.121 0.372-1.123 
      Opiates 1.374 1.09 0.297 0.757-2.496 1.174 0.264 0.608 0.637-2.164 
      Methadone/Suboxone 0.584 0.905 0.342 0.193-1.769 0.577 0.834 0.361 0.177-1.880 
      Sedatives/Benzodiazepines 0.973 0.009 0.925 0.544-1.739 0.903 0.114 0.736 0.498-1.636 
      Alcohol 0.990 0.002 0.966 0.613-1.599 0.959 0.027 0.869 0.585-1.573 
      Pregnancy Not Planned 
   
  1.331 1.114 0.291 0.783-2.262 
      Pregnancy Planned* 
   
  - - - - 
      Married 
   
  0.974 0.01 0.921 0.574-1.652 
      Single* 
   
  - - - - 
     Adolescent Maternal Age 
   
  3.229 2.381 0.123 0.728-14.313 
     Young Maternal Age 
   
  3.236 4.117 0.042 1.041-10.062 
     Average Maternal Age 
   
  1.933 1.306 0.253 0.624-5.987 
     Advanced Maternal Age* 
   
  - - - - 
     Less Than High School 
   
  1.351 0.904 0.342 0.727-2.511 
     High School or Beyond* 
   
  - - - - 
      Less Than $49,000 
   
  1.147 0.113 0.737 0.516-2.551 
      More Than $49,000* 
   
  - - - - 
      White 
   
  1.046 0.009 0.926 0.407-2.686 
      Other* 
   
  - - - - 
      1-5 Pregnancies 
   
 5.064 6.961 0.008 1.518-16.898 
      Greater Than 5 Pregnancies*         -  - - - 
*Reference Category 
         
 Self-esteem, social support, stress, and marijuana were significant effect variables for 
historical IPV only, and with the exception of self-esteem and opiates (p=0.534 and p=0.297 
respectively), these same variables were also significant for current and historical IPV in the 
univariate analysis only (see Table 16).  A one-unit decrease in self-esteem was associated with a 
4.4% decrease in odds for historical only IPV; a one-unit decrease in social support was 
associated with a 4.6% decrease in odds for historical IPV only; a one-unit increase in stress was 
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associated with a 13.4% increase in odds for historical IPV only; and not using marijuana was 
associated with a 49.1% decrease in odds of historical IPV only.  When the independent effect 
variables were evaluated with controls in a multivariate analysis, however, these effect variables 
were no longer statistically significant. Self-esteem, social support, stress, and marijuana were 
statistically significant for historical IPV only (Category 1) (p=0.024, p<0.001, p<0.001, p=0.033 
for each parameter respectively), and social support and stress were statistically significant for 
historical and current IPV (Category 2) (p<0.001, p<0.001 respectively) in the multivariate 
analysis; however, the overall models for historical IPV only and historical and current IPV were 
not statistically significant (p=0.931, p=0.213 respectively).  It is possible then that factors other 
than stress, self-esteem, social support, substance, and alcohol abuse, were responsible for the 
effect noted in the univariate analysis.  The full model was, however, able to explain 30.2% (Cox 
and Snell) and 34.7% (Nagelkerke) of the variance in predicting IPV.  In addition, the overall 
goodness-of-fit for the model is very large (Pearson=.650, Deviance=1.00), leading to 
acceptance of the null that the model is a good fit.  The full model statistically significantly 
predicted IPV better than a reduced model (Ç2 (16) = 379.699, p<.001).  The Likelihood Ratios 
Test indicated that social support and stress were statistically significant effect variables for 
historical only and historical and current IPV in the overall model (Table 17).   
Table 17 
      Multivariate Likelihood Tests for Both Historical IPV Only & Historical and Current IPV 
Effect 
Model Fitting 
Criteria        Likelihood Tests 
  
 
-2 Log Likelihood of 
Reduced Model Chi-Square df p 
  Intercept* 1060.158 0 0 . 
  Self-Esteem 1292.550   232.393 2 0.067 
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Social Support 1070.010 9.852 2 0.000 
  Table 17 (continued)     
Stress 1065.394 5.237 2 0.000 
  Sedatives/Benzodiazepines 1062.080 1.922 2 0.898 
  Alcohol 1060.315 0.158 2 0.979 
  Opiates 1060.258 0.100 2 0.597 
  Methadone/Suboxone 1065.418 5.260 2 0.529 
  Marijuana 1068.110 7.953 2 0.090 
  *Reference category is neither historic nor current IPV 
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CHAPTER 5 
DISCUSSION 
 Intimate partner violence impacts more than 324,000 pregnant women in the U.S. each 
year (CDC, 2013).  Women can experience physical and psychological changes in the cycle of 
abuse, and concomitant substance abuse or alcohol use may also affect current or historical IPV 
(Coker et al., 2002a; Howard, Oram, Galley, Trevillion, & Feder, 2013; Martin, Beaumont, & 
Kupper, 2003 ).  Moreover, pregnancy outcomes can be negatively affected by physical, 
psychological, and sexual IPV (Cascardi, O’Leary, & Schlee, 1999; Finnbogad/ ttir, Dykes, & 
Wann-Hansson, 2014; Han & Stewart, 2014; Haywood, 2014).  The purpose of the current study 
was to better understand IPV as it related to a sample of pregnant Appalachian women selected 
for the TIPS study through an evaluation of psychological, sociocultural, and socioeconomic 
variables as they relate to both current and historical IPV in order to better assess, plan, and 
intervene when IPV is identified in pregnant women presenting for prenatal care.   The purpose 
of Aim 1 was to evaluate the prevalence of historical and current IPV in the study sample, which 
was then contrasted against historical IPV victimization rates in the State of Tennessee and the 
U.S.  The purpose of Aim 2 was to determine the strength of associations against various 
sociocultural covariates in predicting IPV.  Finally, the purpose of Aim 3 was to model 
significant IPV influences from Aim 2 to determine IPV predictors when historical and current 
IPV is present. 
Aim 1 
Aim 1.1 
The purpose of Aim 1.1 was to determine the prevalence of any type of current (HITS) or 
historical (WAST) IPV victimization rates in the TIPS sample, and the crosstabs analysis 
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sufficiently addressed this aim. Of the 1,016 women evaluated in the TIPS sample, 34.83% of 
pregnant women reported historical IPV only, less than 1% reported current IPV only, 16.2% 
reported both historical and current IPV, and 48.9% reported neither historical nor current IPV 
(see Table 1).  It is rare for IPV to begin in pregnancy, with the majority of women who have 
dealt with IPV reporting it occurred in the twelve-month period before conception (Brieding et 
al, 2011).  Existing sexual IPV may instead be the cause of unwanted or unplanned pregnancy 
(Brieding et al, 2011).  Findings in the TIPS sample were consistent with the literature, as less 
than 1% (n=7) of pregnant women reported the initiation of IPV once pregnancy was diagnosed.   
Aim 1.2 
 The purpose of Aim 1.2 was to compare and contrast historical IPV victimization rate 
prevalence (WAST) in the TIPS sample to county level data in Tennessee utilizing the 
TNCrimeOnline database for 2007-2012.  It was hypothesized that the prevalence of self-
reported historical IPV victimization rates in the TIPS study sample would be higher than TN 
county level crime statistics for historical IPV victimization.  For each of the seven Appalachian 
counties represented in the TIPS sample (Carter, Greene, Hawkins, Johnson, Sullivan, Unicoi, 
and Washington), the percent prevalence of historical IPV was higher when compared with TN 
county data for the same counties for the same period (see Table 3).  The TNCrimeOnline 
database, therefore, provided comprehensive county level data to address Aim 1.2. 
Aim 1.3  
The purpose of Aim 1.3 then was to compare and contrast historical IPV victimization 
rate prevalence (WAST) in the Appalachian sample to the United States using U.S. Bureau of 
Justice IPV data from the National Crime Victimization Survey (NCVS) for 2007-2012. It was 
hypothesized that the prevalence of historical IPV victimization rates in the TIPS study sample 
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would be higher than U.S. historical IPV victimization rates.  The overall historical IPV rate per 
1000 population for the TIPS sample was significantly higher than the average IPV crime 
victimization rate per 1000 US population for 2007-2012 in this analysis (510.3 versus 5.5 
respectively).  The U.S. BOJ and TNCrimeOnline databases provided detailed IPV data for 
reported IPV victimization rates; however, reported victimization IPV rates were not equivalent 
for direct comparison to the TIPS sample self-reported IPV data. 
Self-reports and actual reports submitted to law enforcement may be cause for 
discrepancy for Aims 1.2 and 1.3. Total numbers of all types of historical IPV are summated and 
recorded annually from state law enforcement agencies to determine IPV victimization rates per 
1,000 populations for the U.S.  The TIPS sample percent prevalence was converted to rate per 
1,000 to contrast with U.S. rates, and was higher than U.S. IPV victimization rates (see Table 4). 
Sample participants completing the WAST Assessment tool resulted in 100% of the historical 
IPV data in the study sample being obtained through self-report, while the U.S. data is obtained 
from reportable victimization rates submitted to a national depository from state law enforcement 
agencies. It is estimated, however, that one in four women experience IPV, but only 5-10% 
actually report being victimized to law enforcement (Brieding et al, 2015).  It becomes difficult, 
therefore, to compare self-reports to actual reports because national or state data may represent a 
significant proportion of underreported historical IPV victimization rates.   The historical IPV 
victimization rate in the study sample would then appear significantly higher based on a 100% 
response rate to assessments of historical IPV among study participants. In addition, self-report 
can bias the TIPS sample results if the participants did not answer IPV assessment questions 
honestly, did not completely understand assessment questions or scoring ranges, or may have 
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responded positively to only those questions that relate to events occurring regularly (Ezzati et 
al., 2006; Herbert et al, 1994; McCue & Tartaglia, 2010). 
Aim 2 
Aim 2.1 
Aim 2.1’s purpose was to determine the independent effect of self-esteem after 
controlling for income, parity, planned pregnancy, age, marital status, race, and education, on 
predicting an association with IPV. To the author’s knowledge, this is the first study to examine 
this independent effect in relation to current and historical IPV.  After controlling for these 
independent variables, self-esteem did have not a statistically significant effect association with 
historical IPV only (p=0.056) (Category1), but was statistically significant for increased odds of 
historical and current IPV (p=.001) (Category 2) (see Table 7). 
The PPP variable for self-esteem was continuous with participant scores ranging from 11-
44.  No studies in the literature exist that recommend a particular cut-off for high or low self-
esteem.  Rather, it is suggested that higher scores are associated with higher self-esteem, and 
prior studies involving pregnancy and IPV have evaluated study samples in relation to mean self-
esteem or psychological scores before and after pregnancy (Woods et al., 2010).  The mean score 
for self-esteem for the TIPS sample was 35.6 (SD=5.871) (see Table 5), suggesting that self-
esteem was moderate to high when compared to prior studies of PPP self-esteem mean score 
correlations in culturally diverse prenatal populations (Curry, et al., 1998).  Determining a 
predictive relationship of self-esteem to historical or current IPV cannot be definitive in this 
analysis.  Findings would seem to suggest that low self-esteem is associated with historical and 
current IPV, but only approached significance for the subjects reporting historical IPV only. 
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In the multivariate analysis for the independent effect of self-esteem in a predictive 
model for IPV, however, a control variable representing whether or not a pregnancy was planned 
was also significant for historical IPV only (p=0.001); p=0.041 for subjects reporting both 
historical and current IPV compared to those women who reported planned pregnancies.  There 
is some evidence in the literature that high levels of self-esteem can moderate a woman’s 
perception of sexual risk in relation to unplanned pregnancy (Ethier et al., 2006; Smith, Gerard, 
& Gibbons, 1997).  In the TIPS sample, it appeared that levels of self-esteem were not low 
overall, but the majority of pregnancies in the sample were not planned (n=713).  Of those 
reporting historical IPV only, 39.6% reported unplanned pregnancy, and 18.9% of those 
reporting current and historical IPV also reported unplanned pregnancies.  It is possible, 
therefore, that the influence of low levels of self-esteem and unplanned pregnancy when IPV is 
present needs further evaluation.  
Aim 2.2 
 Aim 2.2’s purpose was to determine the independent effect of social support after 
controlling for income, parity, planned pregnancy, age, marital status, race, and education, on 
predicting IPV. After controlling for these independent variables, social support was statistically 
significant for increased odds in an association with historical only and historical and current 
IPV only (p<.001, p=0.019) (Category 2) in the multivariate analysis (see Table 8).  The range of 
social support scores for the sample was 12-66, with a mean score of 52.8 (SD=10.232) (see 
Table 5), suggesting that perceived levels of social support for the overall sample was high 
(Curry et al., 1998). Of those reporting historical and current IPV, 24% (n=39) reported higher 
levels of social support, with the remaining 75% (n=121) reporting levels of social support below 
the mean.  This study’s findings support prior research in relation to current and historical IPV 
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that found high levels of social support are associated with reduced levels of poor mental health, 
anxiety, PTSD, and depression (Coker et al., 2002b; Rose et al., 2010). 
 In the multivariate analysis for the independent effect of social support to predict IPV, 
whether or not a pregnancy was planned was again significant (p=.002) when compared with 
women reporting planned pregnancies and neither historical nor current IPV.  Unwanted 
pregnancies are associated with increased levels of stress and depression, and lower levels of 
social support are also associated with stress and depression when IPV is present (Coker et al., 
2002b; Dibabba, Fantahun, & Hindin, 2013; Rose et al., 2010).  The study findings suggest 
reflect lower levels of perceived social support in the women studied who reported historical and 
current IPV, which is consistent with other findings in the literature. 
The nature of the differences in the statistical relationship between social support and 
those pregnant women experiencing either historical only or historical and current IPV is 
unclear.  It is possible that women who have experienced IPV in the past and also during 
pregnancy have a higher level of repeated exposures to IPV when compared to women who only 
experienced IPV in the past.  Women who only experienced IPV in the past may have left an 
abusive partner, and these women may be significantly different from those that remain in 
abusive relationships in terms of levels of social support. Women experiencing situational or 
episodic violence (historical IPV) may be exposed to less controlling influences by an abusive 
partner than those that are repeatedly exposed to violence (Frye et al., 2006), which may also 
affect the degree of social support they report on the PPP.  Further, the relationship between 
social support and unplanned pregnancy in women experiencing IPV represents an opportunity 
for further study before this association can be generalized to all pregnant women experiencing 
IPV. 
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Aim 2.3 
 Aim 2.3’s purpose was to determine the independent effect of stress after controlling for 
income, parity, planned pregnancy, age, marital status, and race.  Stress was statistically 
significant for increased odds of predicting historical only (Category 1) (p<.001) and historical 
and current IPV (Category2) (p<.001) in the multivariate analysis (see Table 9).  The range of 
stress scores for the sample was 11-38, with a mean score of 18.86 (SD=2.066) (see Table 5), 
suggesting that perceived levels of stress for the sample was low (Curry et al., 1998).  Of those 
reporting historical IPV only, 57.1% (n=198) were above the mean for perceived stress, while 
75.2% (n=124) of pregnant women reporting historical and current IPV had perceived stress 
scores above the mean.  The results suggest then that the majority of pregnant women in the 
sample had higher perceived levels of stress when compared to pregnant women not reporting 
IPV (32.6%, n=95).  Findings for women reporting historical and current IPV are consistent with 
findings in the literature that found pregnant women experiencing IPV had higher levels of 
perceived stress (Coker et al., 2002b; Dibabba, Fantahun, & Hindin, 2013; Flanagan et al., 2015; 
Rose et al., 2010).  Studies involving stress, pregnancy, and IPV are diverse in method and 
population making it difficult to compare the findings of this study and this population with 
others that have found contradictory findings for women reporting historical IPV only.  
Replication of this study with diverse populations and settings might yield different findings and 
represents an opportunity for further research. 
 Both achieved “education less than high school” and “unplanned pregnancy” were also 
significant in the independent evaluation of stress as a predictor of historical IPV only (p=.024 
and p=.002 respectively) when compared with women achieving a high school diploma or 
beyond and those reporting planned pregnancies.  As previously noted, higher levels of stress are 
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associated with IPV, but evaluations of education, and unplanned pregnancy, that also evaluate 
perceived levels of stress while IPV is present, are missing in the literature.  It is more common 
to evaluate education as a descriptive variable for a sample.  It is unclear, however, what 
relationship unplanned pregnancy and education had on perceived levels of stress when historical 
IPV was present in the study group.  This represents another opportunity for further evaluation in 
order to validate the study sample findings against other populations. 
 Women having between one and five pregnancies was also significant with historical and 
current IPV only (Category 2, p=.036) when compared with women having greater than five 
pregnancies and reporting neither historical nor current IPV.  The literature is sparse in its 
evaluation of parity and IPV, but there is some evidence that such a relationship does exist.  
Researchers evaluating IPV in multi-racial studies have found a correlation between women 
having two or more pregnancies and IPV (Palmetto et al., 2013), and an increased risk of 
becoming pregnant again within three months of delivery if IPV is present (Edin & Nilsson, 
2013). One other study did note positive associations between an abusive partner’s desire to 
initiate a pregnancy, interfering with their partner’s use of contraception, or the inability to afford 
contraception as being risk factors for initial or subsequent pregnancies when IPV is present 
(Gee et al., 2009).  It is unclear if women in the TIPS sample who reported unplanned 
pregnancies became pregnant as a result of sexual or physical IPV, or if this relationship is 
unique to this population.  Further evaluation of sexual IPV and contributing factors to 
unplanned pregnancy in the TIPS or other population samples might yield more supporting data 
for this contention. 
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Aim 2.4 
 Aim 2.4’s purpose was to determine the independent effect of substance abuse after 
controlling for income, parity, planned pregnancy, age, marital status, and race. Marijuana, 
opiates, methadone/suboxone, and sedatives/benzodiazepines were evaluated individually rather 
than evaluating a combined variable for all substance abuse in the study sample.  
 Marijuana.  After controlling for the independent control variables above, marijuana use 
did have statistically significant odds for predictive ability with historical and current IPV only 
(Category2) in both the univariate and multivariate analyses (p<.001, p=.003 respectively) (see 
Table 11). This finding is consistent with existing studies that found a relationship between 
marijuana and IPV (Alhusen, Lucea, Bullock, & Sharpe, 2013; Bailey & Daugherty, 2007; El-
Bassel et al., 2005).  Unplanned pregnancy was again significant in the univariate and 
multivariate evaluation (p<.001, p=.003) of independent effect of marijuana use to predict 
historical and current IPV (Category 2) when compared with women not using marijuana and 
reporting neither historical or current IPV.  To the author’s knowledge, there is no evidence that 
the use of marijuana is associated with unplanned pregnancy when IPV is present, but there is 
some evidence of associations between marijuana use and unplanned sex or pregnancy (Hingson 
et al., 2003; Martino et al., 2006).  The evaluation of a relationship between marijuana use, low 
income, and IPV is an opportunity for further study. 
 Opiates.  Use of opiates in pregnancy was statistically significant for odds of predicting 
historical IPV only (Category 1) in the univariate and multivariate analyses (p=.002, p<.001), 
and in the multivariate analysis of current and historical IPV (Category) (p=.021) (see Table 12) 
after controlling for the above independent variables. Low income, being married, and an 
unplanned pregnancy were also statistically significant (p=.043, p=.031, and p=.01 respectively) 
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in the multivariate analysis of the independent effect of opiate use historical and current IPV 
when compared with women with income greater than $44,298 per year, single women, and 
those reporting planned pregnancies.   Pregnant women using opiates in the study sample 
achieved high school education or beyond (78.7%, n=155), had incomes greater than $44,298 per 
year (81.6%, n=749), and 81.1% (n=579) had planned pregnancies.  Poor women are more likely 
to have unintended or unwanted pregnancies (Finer & Zolna, 2014). To the author’s knowledge, 
there is no evidence suggesting a combined effect for women using opiates during pregnancy and 
higher incidence of historical or current IPV, lower levels of income, being married, and 
unplanned pregnancies.  There is no evaluation in the literature of the independent effect of 
opiate use in pregnancy and IPV as a predictor, giving the results of the present study no basis 
for comparison, but also representing a unique evaluation of this phenomenon’s predictive ability 
for IPV. 
Methadone/Suboxone. Use of methadone or suboxone in pregnancy was statistically 
significant for its predictive ability of historical IPV only (Category 1) in both the univariate and 
multivariate analyses (p=.001, p=.005 respectively) (see Table 13) after controlling for the above 
independent variables.  There is no evaluation in the literature of the independent effect of 
methadone or suboxone use in pregnancy as a predictor of IPV, giving the results of the present 
study no basis for comparison.  The present study’s results again present a unique evaluation of 
this type of substance abuse and its predictive ability for IPV. 
Education less than high school and unplanned pregnancy were again statistically 
significant (p=.026, p<.001 respectively) in the multivariate analysis of the independent effect of 
methadone/suboxone use in historical IPV only when compared with women achieving greater 
than a high school diploma and those women reporting planned pregnancies.   Income less than 
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$44,298 was also significant for historical and current IPV (p=.050) when compared with women 
making greater than $44,298 (see Table 13).  A small percentage of pregnant women using 
methadone or suboxone in the study sample also had less than a high school education, and had 
unplanned pregnancies.   This would suggest that the majority of the study sample had higher 
levels of achieved education, higher incomes and had planned pregnancies; however, there is 
similar evidence to the contrary.  Near equivalent numbers of study participants also had a high 
school diploma or higher, had incomes higher than $44,298, and reported planned pregnancies 
when compared to women who did not use methadone or suboxone in pregnancy. 
Methadone has been frequently used to assist with supervised narcotic withdrawal from 
opiate addiction for over 40 years (MedlinePlus, 2014), and suboxone (buprenorphine) is a 
newer medication that is also used to treat opiate withdrawal and dependence (MedlinePlus, 
2015).  The current study did find a statistically significant relationship between the use of 
methadone/suboxone and historical IPV in Appalachian women.  Lower levels of achieved 
education and unplanned pregnancies were also statistically significant for pregnant women in 
the TIPS study using methadone or suboxone.  
Sedatives/Benzodiazepines. Use of sedatives or any type of benzodiazepines in 
pregnancy was statistically significant for odds of predicting historical IPV only (Category 1) 
(p=0.001), and historical and current IPV (Category 2) (p<0.001) in the univariate analysis, and 
also significant for increased odds of predicting historical and current IPV (p=0.019) after 
controlling for the above independent variables (see Table 14).  A prior study evaluated the 
effect of sedative/benzodiazepine use in pregnancy and IPV, but these findings relate a pregnant 
woman’s sedative use to the physical aggression of their alcoholic partner (Mattson et al., 2012), 
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giving the results of the present study no basis for comparison.  The present study’s results again 
present a unique evaluation of this type of substance abuse and its predictive ability for IPV. 
Income, education, and whether or not a pregnancy was planned were again statistically 
significant (p=.024, p=.043, p<.001 respectively) in the multivariate analysis of the independent 
effect of sedatives/benzodiazepines use in historical and current IPV when compared with 
pregnant women not using sedatives/benzodiazepines.  A small percentage of pregnant women 
using sedatives or benzodiazepines in the study sample also had less than a high school 
education, had incomes less than $44,298 per year, and had unplanned pregnancies.   There is 
similar evidence to the contrary with near equivalent numbers of pregnant women having a high 
school diploma or higher, having incomes higher than $44,298, and reporting planned 
pregnancies when compared to women who did not use sedatives or benzodiazepines in 
pregnancy.  Descriptive characteristics for education, income, and whether or not a pregnancy 
was planned within this subpopulation of women using benzodiazepines or sedatives and 
experiencing IPV are, therefore, similar, and the findings neither support nor discount 
uniqueness in this study sample.  Sedative or benzodiazepine’s predictive ability for historical 
IPV did, however, demonstrate a statistically significant relationship.  
Aim 2.5  
 The purpose of Aim 2.5 was to determine the independent effect of alcohol after 
controlling for income, parity, planned pregnancy, age, marital status, and race to predict IPV.  
Use of alcohol in pregnancy was statistically significant in odds of predicting historical and 
current IPV in the univariate analysis only (p=0.03) (see Table 15); however, historical only and 
IPV was significant in the univariate and multivariate analyses (p<0.001, p<0.001), and 
historical and current IPV was significant in the univariate analysis only (p=0.01).  The use of 
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alcohol in women experiencing IPV has had limited evaluation in pregnant women (Li et al., 
2010; Martin, Beaumont, & Kupper, 2003), with socioeconomic status being a more common 
evaluation of alcohol use in pregnancy (Alvanzo & Svikis, 2008; Li et al., 2010).   Such a study 
is, therefore, not available for comparison to the current study’s findings. 
 Less than high school education, and unplanned pregnancy were again statistically 
significant (p=.011, p<.001 respectively) in the multivariate analysis of the independent effect of 
alcohol use in historical only IPV; being married and lower income were additionally significant 
with the above for historical and current IPV (p=.028, p=.008, p=.048, and p=.038 respectively).  
Pregnant women using alcohol and experiencing historical IPV in the study sample had 
equivalent levels of achieved education, reported near equivalent rates of either planned or 
unplanned pregnancies, were approximately equal in marital status, and have near equivalent 
incomes when compared to women who did not use alcohol in pregnancy.  These subpopulations 
are similar, suggesting that the findings do not positively or negatively support uniqueness in 
these characteristics.  Alcohol’s predictive ability for historical and current IPV was, however, 
statistically significant. 
Aim 3 
 The purpose of Aim 3 was to examine the joint effects of psychological, substance abuse, 
and sociocultural covariates in predicting IPV by examining statistically significant predictors of 
IPV from Aim 2 in a multivariate analysis.  All of the psychological variables (self-esteem, 
social support, stress), all of the substance abuse variables (marijuana, opiates, 
methadone/suboxone, sedatives/benzodiazepines) and alcohol were significant predictors for 
historical IPV only and/or current and historical IPV.  The multinomial logistic regression model 
(see Tables 16 and 17) found that these independent effect variables were significant predictors 
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for historical IPV only (p<.001) and historical and current IPV (p<.001) in the univariate 
analysis only. After controlling for age, race, income, marital status, parity, education, and 
whether or not a pregnancy was planned, the psychological, substance abuse, and alcohol, the 
independent effect variables from Aim 2 were not statistically significant predictors for historical 
IPV only or current and historical IPV (p=.913, p=.213). 
Studies examining historical and current IPV are rare in the literature.  One prior study 
did examine historical and current IPV, but the context of this earlier study was the 
determination of physical health effects when IPV was present (Coker et al., 2000). The 
psychological effects of physical, psychological, and sexual abuse in women have been widely 
studied (Bailey & Daugherty, 2007; Campbell, 2002; Coker et al., 2000; Coker et al., 2002a;), 
and the relationship between substance abuse or alcohol abuse and IPV has also been evaluated 
in the literature (ACOG, 2015b; Goodman & Wolff, 2013; Kiely et al., 2013).  This is the first 
study to the author’s knowledge that has modelled these combined groups of variables as 
potential predictors of IPV.  Therefore, while this methodology represents a significant addition 
to the body of knowledge in identification of predictors of IPV, it makes comparison to other 
studies difficult. 
The results of the present study did not show an association between these psychological 
and substance abuse variables and historical IPV.  It was interesting to note that while historical 
IPV only (Category 1) was not significant in this analysis, self-esteem (p=.005), stress (p<.001), 
social support (p<.001), and marijuana (p=.001) were statistically significant in the multinomial 
logistic regression analysis.  The independent effect of marijuana was a statistically significant 
predictor for historical IPV only in Aim 2, and this effect was reproducible when all independent 
effect variables and controls were evaluated together (p=0.033).  Similarly, with the exception of 
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self-esteem’s relationship with historical and current IPV in the univariate and multivariate 
analyses (p=.534, p=.574), social support, and stress were all statistically significant predictors of 
historical only (Category 1) and current and historical IPV (Category 2).  They were significant 
in a group analysis of independent effects variables only, but were not significant as predictors 
for IPV in the final model.  It is possible that the effect of these variables on IPV represents a 
mediator or moderator relationship, and not a predictive relationship.  Statistically significant 
control variables in the evaluation of independent effects variables in Aim 2 included unplanned 
pregnancy only, which was significant (p=.007) in the multivariate analysis of historical IPV 
only for the final predictive model of Aim 3. 
The overall goal of Aim 3 was met, with self-esteem, social support, stress, and substance 
and alcohol abuse being evaluated as predictors for historical or current IPV. The selected 
psychological and sociocultural variables were not predictive of historical or current IPV when 
controlling variables were included in the final predictive model.  While none of these selected 
variables individually or collectively were able to demonstrate predictive ability for IPV, the 
current study has contributed to the body of knowledge by illustrating that factors associated 
with IPV risk are multi-factorial and complex.  Appalachian women experiencing IPV may 
represent population uniqueness, and replication of this study in diverse populations in diverse 
settings may support this type of model’s predictive ability for IPV in the future.  
Strengths 
 The current study gives strength to the existing literature on IPV in several ways.  First, 
this is the only study to the author’s knowledge that has attempted to model IPV prediction 
utilizing both psychological (self-esteem, social support, stress) and sociocultural (substance and 
alcohol abuse) variables.  While more traditional control variables were used (age, education, 
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income, race, marital status), the study also exclusively examined nontraditional variables as 
controls (parity, whether or not a pregnancy was planned) to further explain the phenomena of 
IPV.  Second, the current study is exceptional in its concurrent evaluation of current and 
historical IPV.  The WAST and the HITS assessment tools evaluated current and historical IPV 
in pregnant study participants, which represents a unique use of these tools, as these tools were 
originally designed for implementation in family practice (Brown et al., 1996; Sherin et al., 
1998). Third, this study expands the limited existing literature on the simultaneous use of WAST 
and HITS to evaluate IPV.  While these assessment tools have been used in the past to evaluate 
IPV in women (Chen et al., 2005; Chen et al., 2007; Ghandi et al., 2010), this study’s 
simultaneous use of these tools to examine current and historical IPV in an exclusively pregnant 
population is again, unique. Fourth, this is the only study that has evaluated simultaneous cut-off 
values for the WAST and HITS assessments. A score of two as a potential cut-off value for the 
full WAST tool to capture responses of “often” on any of questions 3-8 was evaluated, rather 
than utilizing a score of two as suggestive of positive IPV on the WAST-Short Form (questions 1 
and 2) (Cheung & Liebschultz, 2002). After computing the IPV variable, the number of WAST 
positive only study participants remained the same (n=347).  In addition, the use of a score of 
seven as being positive for current IPV in pregnancy for the HITS variable represents an 
expansion of an earlier study that evaluated a score of six or seven as a suggested cut-off 
(Iverson et al., 2015).  The number of study participants that were positive for current IPV at this 
cut-off level after the IPV variable computation also remained the same (n=7).  This suggests 
that the WAST and HITS variables with the above cut-offs values correctly categorized study 
participants that were positive for current or historical IPV. 
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Limitations 
 Research findings often have limitations in their findings and study approach, and this is 
true for the current study as well.  The TIPS study sample recruited its participants as part of a 
study for tobacco cessation interventions for pregnant women.  Because of the study’s selection 
criteria, it is possible that this population may also be unique in characteristics for social support, 
self-esteem, stress, substance, and alcohol abuse and not be representative of other pregnant 
women in Appalachia.  Replication of this study with more random selection of pregnant 
participants not based on tobacco use could yield different results. 
 Original WAST and HITS assessment scores were recorded as continuous data variables.  
As part of the investigation of the present study, both variables were dichotomized to evaluate a 
score of two or greater for the WAST, and a score of seven or greater for the HITS. These new 
variables were then used to compute a new variable “IPV” to create the three investigational IPV 
categories – WAST positive only, WAST and HITS positive, and WAST and HITS negative.  It 
is possible that the cut-offs values may have overestimated rates for current or historical IPV.  It 
is further possible that this affect may have been unique to this study population since these cut-
off values have not been evaluated before in a demographically similar population.  Use of these 
proposed cut-off values would need replication to determine if these findings are consistent in 
diverse pregnancy populations and in diverse settings. 
 Use of the WAST and HITS as a brief assessment of IPV may have limited the collection 
of IPV data.  As a baseline assessment, there was no comparison data for the assessment of IPV 
at other points in the pregnancy, which may have yielded a more rich assessment of IPV 
prevalence over time.  In addition, because these instruments rely on self-report, the information 
obtained may be inaccurate due to lack of comprehension for either individual questions or for 
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the scoring scale, or may have included false reports of IPV on behalf of some of the study 
participants. 
Translational Implications 
 The current study was unable to support prior findings regarding the role of 
psychological indicators, substance abuse, and historical and current IPV. The statistical 
significance in the univariate predictive model of self-esteem, social support, stress, and 
marijuana in the present study does support prior findings related to potential associated risk 
factors for IPV, and those factors that are commonly associated with the experience of IPV.  
Further, while unplanned pregnancy was statistically significant with all of the independent 
effect variables (self-esteem, social support, stress, substance and alcohol abuse), in the final 
model it had a significant relationship with historical IPV only.  This suggests that for pregnant 
women in the TIPS sample, unplanned pregnancy may moderate the relationship between these 
independent factors and IPV. 
 Increasing provider opportunities to assess for risk and signs of IPV is important when 
women present for well care or for initial pregnancy care.  Current best practice does recommend 
screening for IPV at the initial prenatal visit, and under the Affordable Care Act, all women 
qualify for IPV screening at no cost regardless of their ability to pay (Liebshutz & Rothman, 
2012).  Women may, however, present for initial pregnancy visits at various weeks of gestation, 
thus limiting the amount of occasions available for subsequent IPV screening.  An initial IPV 
screen should then be completed as a baseline measure using both the HITS and WAST 
screening tools whenever the initial pregnancy visit occurs, but IPV screening should be repeated 
at least twice more prior to delivery.  A second opportunity for IPV screening could occur when 
women present for an anomaly ultrasound scan at approximately 18-20 weeks gestation.  
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Compliance with these types of screening ultrasounds is usually high when antenatal education 
has been provided consistently (Chawla, Ballal, & Kushtagi, 2012).  A third opportunity for IPV 
screening could occur in late second trimester or early third trimester pregnancies when glucose 
tolerance tests are most likely to be performed (Brown, 2014).   These opportunities already 
capture women for screening, and subsequent IPV screening should also occur at these times to 
provide multiple opportunities for providers and nursing staff to assess for IPV risk in 
pregnancy.  Provider offices and clinics must make staffing resources available that are dedicated 
to assisting in IPV screening to facilitate IPV awareness and risk prevention in pregnancy. 
Preventing unwanted or unplanned pregnancy is a critical element when IPV is present.  
Because all forms of IPV place a woman at risk for unplanned pregnancy (Gao, Paterson, Carter, 
& Lusitini, 2007; Gazmarian et al., 1995; Goodwin et al., 2000; Pallitto & O’Campo, 2004), 
family practice, obstetrics and gynecology providers, and county health departments must 
provide contraceptive counseling at every clinical visit, regardless of the nature of the visit.  
Women presenting for well check-ups or sick visits are in a unique position to receive such 
counseling from providers, nursing staff, or facility educators.  One-on-one education is ideal 
and should be carried out without the presence of a significant other to allow the opportunity for 
a woman to discuss concerns such as pregnancy prevention and safety risks in the home.  
Follow-up appointments should always be strongly encouraged and made before a woman 
returns to her home, and this can provide an opportunity to assess transportation needs and 
access, which will assist to reduce occurrence of noncompliance.  When a woman presents to a 
provider office or clinic once a pregnancy has already taken place, she may be forced into a 
decision about pregnancy termination that might have been avoided if contraceptive counseling 
had been made available during prior provider visits.  
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 In order for communities and public health entities to impact the prevalence of IPV, it 
will be necessary to coordinate the care of pregnant women across various continuums.  First, 
providers must collaborate and consult with one another regardless of the setting in which they 
deliver care services for women.  Best practices can then be shared, replicated, and become 
consistent so that providers become committed to screening for IPV prevalence in the same ways 
and at the same times during pregnancy.  Second, increased IPV risk awareness in pregnant 
women for community and family members can be accomplished through regular public health 
educational forums, literature, and public service announcements delivered and made available at 
various locations such as provider offices, community centers, churches, and schools.  These 
forums and literature should promote awareness of community programs, services, shelters, and 
family support that are available to assist families in crisis.  Third, contraceptive and IPV risk 
education should begin early for girls beginning in middle school.  IPV is not exclusive to 
women of a particular age, dating violence can result in unplanned pregnancy, and it is estimated 
that one in ten adolescent and young women report dating violence each year (CDC, 2014b).  It 
is only through careful, trusted, and open conversations with young women, that IPV risk can be 
reduced, and unplanned pregnancies that may result from IPV can be avoided. 
Conclusion 
 The current study has confirmed that variations in self-esteem, social support, stress, and 
maternal substance/alcohol abuse may have a relationship with historical and current IPV.  While 
this study has not definitely shown predictive power for these variables in relation to IPV in the 
TIPS study sample, it has highlighted that IPV is a complex phenomenon, and many factors may 
have a role in IPV risk and prevalence.  The lack of support in these findings for predictive 
ability with IPV only underscores the importance of uniqueness in various populations and 
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across various regions such as Appalachia.  In addition, the need for repetitive IPV screening and 
community education can have a positive effect in reducing IPV prevalence for pregnant women 
when there is a history of IPV prior to pregnancy, and when IPV continues once a pregnancy 
begins.  
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APPENDICES 
Appendix A 
 WAST Assessment Tool
     
    
 
WAST 
 
 
1.  In general, how would you describe your relationship…  
A lot of tension (2)  Some tension (1)  No tension (0) 
 
 
2.  Do you and your partner work out arguments with…  
Great Difficulty (2)  Some Difficulty (1)  No difficulty (0) 
 
 
3.  Do arguments ever result in you feeling put down or bad about yourself?  
Often (2)  Sometimes (1)  Never (0) 
 
 
4.  Do arguments ever result in hitting, kicking, or pushing?  
Often (2)  Sometimes (1)  Never (0) 
 
 
5.  Do you ever feel frightened by what your partner says or does?  
Often (2)  Sometimes (1)  Never (0) 
 
 
6.  Has your partner ever abused you physically?   
Often (2)  Sometimes (1)  Never (0) 
 
 
7.  Has your partner ever abused you emotionally?   
Often (2)  Sometimes (1)  Never (0) 
 
 
8.  Has your partner ever abused you sexually?   
Often (2)  Sometimes (1)  Never (0) 
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Appendix B 
HITS Assessment Tool      
    
 
 
HITS 
 
 
Please respond to the questions below using the following scale: 
 
 1=eever 
 2=Rarely 
 3=Sometimes 
 4=Fairly often 
 5=Frequently 
 
 
Since you were pregnant, has a partner or ex-partner 
 
_____  1.  Physically hurt you? 
 
_____  2.  Insulted you fairly often? 
 
_____  3.  Threatened you? 
 
_____  4.  Screamed at you fairly often? 
 
_____  5.  Forced unwanted sexual activity? 
 
 
 
 
 
 
 
Appendix C 
 Pregnancy Psychological Profile Assessment Tool 
PPP Stress 
 
Below is a list of factors that might be stressful in your life right now. Please indicate the level 
of stress or hassle you feel each of the following causes you. 
 
            No  Some         Moderate    Severe 
         Stress Stress Stress       Stress 
              1                 2                    3    4 
______________________________________________________________________ 
 
1.  Financial worries (e.g. food, shelter, 
 health care, transportation)                   1        2        3    4 
 
2.  Other money worries (bills, etc)         1       2        3    4 
 
3.  Problems related to family (partner, 
 children, etc)                    1       2        3    4 
 
4.  Having to move, either recently or 
 in the future            1       2        3    4 
 
5.  Recent loss of a loved one          1       2        3    4 
 
6.  Current pregnancy           1       2        3    4 
 
7.  Current abuse (sexual, emotional, 
 physical)            1       2        3    4 
 
8.  Problems with alcohol and/or drugs         1       2        3    4 
 
9.  Work problems (e.g. being laid off, trouble 
 with boss/co-workers, etc.)          1       2        3     4 
 
10.  Problems related to friends          1       2        3     4 
 
11.  Feeling generally “overloaded”         1       2        3     4 
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PPP Social Support 
 
The next set of questions asks how satisfied you are with the amount of support you receive 
from your partner and/or other people. 
 
First of all, do you have a partner? 
 _____    No (answer only about support from others) 
 _____    Yes 
 
Below is a list of statements describing types of support. On a scale of 1 to 6, with 1 being 
very dissatisfied and 6 being very satisfied, indicate how satisfied you are with the support 
you receive from your partner and/or other people. 
________________________________________________________________________________ 
       Partner      Other People 
          Very     Very                  Very     Very  
           Dissatisfied Satisfied    Dissatisfied Satisfied 
________________________________________________________________________________ 
 
1.  Shares similar experiences 
 with me    1    2    3    4    5    6   1    2    3    4    5    6 
 
2.  Helps keep up my morale  1    2    3    4    5    6   1    2    3    4    5    6 
 
3.  Helps me out when I am in a pinch 1    2    3    4    5    6   1    2    3    4    5    6 
 
4.  Shows interest in my daily activities 
 and problems   1    2    3    4    5    6   1    2    3    4    5    6 
 
5.  Goes out of his/her way to do special 
 or thoughtful things for me  1    2    3    4    5    6   1    2    3    4    5    6 
 
6.  Allows me to talk about things that  
 are very personal and private 1    2    3    4    5    6   1    2    3    4    5    6 
 
7.  Lets me know I am appreciated for 
 the things I do for him/her  1    2    3    4    5    6   1    2    3    4    5    6 
 
8.  Tolerates my ups and downs and 
 unusual behaviors   1    2    3    4    5    6   1    2    3    4    5    6 
 
9.  Takes me seriously when I have 
 concerns    1    2    3    4    5    6   1    2    3    4    5    6 
 
10.  Says things that make my situation 
 clearer and easier to understand 1    2    3    4    5    6   1    2    3    4    5    6 
 
11.  Lets me know that he/she will be 
 around if I need assistance 1    2    3    4    5    6   1    2    3    4    5    6 
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________________________________________________________________________________ 
 
PPP Self-Esteem 
 
Finally, we all have some kind of “picture” of ourselves we carry with us. Below is a list of 
statements that people have used to describe themselves. Please indicate how much you 
agree or disagree with each. 
 
         Strongly               Strongly 
           Agree Agree  Disagree Disagree 
              1                 2                    3        4 
___________________________________________________________________________ 
 
1.  I feel that I am a person of worth, at 
 least on an equal basis with others.      1        2        3        4 
 
2.  I feel that I have a number of good 
 qualities.            1       2        3        4 
 
3.  All in all, I feel that I am a failure.                1       2        3        4 
 
4.  I feel I am able to do things as well 
 as most other people.          1       2        3        4 
 
5.  I feel I do not have much to be proud of.    1       2        3        4 
 
6.  I take a positive attitude toward myself.      1       2        3        4 
 
7.  On the whole, I feel satisfied with myself.   1       2        3        4 
 
8.  I wish I could have more respect for 
 myself.            1       2        3        4 
 
9.  I feel useless at times.           1       2        3        4 
 
10.  At times I think I am no good at all.         1       2        3        4 
 
11.  I feel like I have control over my life.         1       2        3        4 
___________________________________________________________________________ 
 
 
 
 
Appendix D 
 T-ACE Assessment Tool
     
    
 
 
T-ACE 
 
______________________________________________________________________________ 
   
 
 
 
 
T How many drinks does it take to make  = 0  if <3 drinks 
 you feel high (TOLERANCE)?   = 2  if 3 or more drinks 
 
            (3 beers, 3 glasses of wine,  
     3 drinks of liquor) 
 
 
A Have people ANNOYED you by criticizing  =  1 if positive 
 your drinking? 
 
 
 
C Have you felt you ought to CUT DOWN on   =  1 if positive 
 your drinking? 
 
 
 
E Have you ever had a drink first thing in the  = 1 if positive 
 morning to steady your nerves or get rid of 
 a hangover (EYE-OPENER)? 
 
 
______________________________________________________________________________ 
Sokol RJ, Martier SS, Ager JW. The T-ACE Questions: Practical prenatal detection of risk drinking. American 
Journal of OB/GYN, 160(4): 863-70, 1989. 
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Appendix E 
 TIPS Study IRB Approval Forms
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Appendix F 
Informed Consent for TIPS Study Participation 
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Appendix G 
TIPS Study Demographic Questionnaire 
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